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Resumo 
 As aquaporinas (AQPs) são proteínas transmembranares que facilitam a difusão da água 
e glicerol através das membranas celulares, cruciais para a homeostase da água e metabolismo. 
As AQPs encontram-se sobre-expressas em diversas células e tecidos cancerígenos, estando 
envolvidas na proliferação, migração celular e tumorigénese, revelando o seu potencial como 
alvos terapêuticos. A identificação de novos inibidores de aquaporinas é essencial. Neste trabalho, 
foram avaliados compostos metálicos (polioxometalatos, compostos de vanádio, cobre, zinco e 
ouro) como inibidores de aquaporinas, utilizando como modelos celulares eritrócitos humanos 
(RBCs) e leveduras transformadas com aquaporinas humanas. O efeito inibidor das AQPs foi 
avaliado pela determinação da permeabilidade membranar à água e ao glicerol, utilizando a 
técnica de stopped-flow. O polioxotungstato-A (POT-A) revelou ser um inibidor da AQP3, com 
um IC50 de (0.71 ± 0.04) µM em RBCs. Em leveduras, POT-A inibiu AQP3 a 100%, confirmando 
os resultados obtidos para os RBCs. O composto de vanádio P103 inibiu AQP1 com um IC50 de 
(9.11 ± 0.03) µM em RBCs. O composto de ouro RBA29, mostrou inibir a AQP3 em RBCs com 
um IC50 de (2.29 ± 0.03) µM. Ainda, os compostos RBA29, RBA31 e STAM013 mostraram inibir 
a AQP9 em leveduras, com um IC50 de (6.64 ± 0.09) µM para RBA29. Neste trabalho, foi também 
avaliado o efeito de mutações na permeabilidade da AQP5 através da técnica de stopped-flow. 
Deste modo, foi descrito um novo mecanismo de regulação em que His73 localizada no filtro de 
seletividade interage com Ser183 fosforilada, levando à constrição do poro. Foi também avaliada 
a função de aquaporinas de diversos organismos, em que a aquaporina de tardígrado revelou maior 
permeabilidade e seletividade para a água do que as outras aquaporinas testadas. Os resultados 
obtidos contribuem para a descoberta e desenho de inibidores seletivos com aplicação terapêutica.  
 
 
 
 
Termos chave: aquaporinas; permeabilidade; inibidores; cancro. 
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Abstract 
Aquaporins (AQPs) are transmembrane proteins that facilitate the diffusion of water and 
glycerol across cell membranes, crucial for water and energy homeostasis. These proteins were 
found overexpressed in different cancer cells and tissues, being involved in tumor formation, cell 
proliferation and migration, suggesting their great potential as drug targets for cancer treatment. 
Identification of novel aquaporin modulators to be used in cancer therapeutics is of utmost 
importance. In this study, the inhibitory effect of polyoxometalates, vanadium, copper, zinc and 
gold-based compounds was screened by the stopped-flow technique in human red blood cells 
(RBCs) and then validated in aquaporin-expressing yeast cells. From the set of polyoxometalates, 
polyoxotungstate-A (POT-A) revealed as the most promising AQP3 inhibitor with an IC50 of (0.71 
± 0.04) µM. Using yeast cells individually expressing human aquaporins, POT-A showed to 
selectively inhibit AQP3 with 100% inhibition, corroborating the results of RBCs assays. The 
vanadium compound P103, showed highly inhibition of AQP1 with an IC50 of (9.11 ± 0.03) µM in 
RBCs. The gold-based compound RBA29 revealed as a promising AQP3 inhibitor with an IC50 of 
(2.29 ± 0.03) µM in RBCs. Moreover, compounds RBA29, RBA31 and STAM013 showed an 
inhibitory effect in AQP9-tranformed yeasts, with an IC50 of (6.64 ± 0.09) µM for RBA29. In 
addition, investigation of the channel residues important for AQP5 permeability revealed a new 
gating mechanism where His73 located in the selectivity filter interacts with phosphorylated 
Ser183, conducting to the pore constriction. Furthermore, the activity of aquaporins from diverse 
organisms was evaluated, wherein aquaporin from tardigrade revealed to be water selective and 
exhibited higher water permeability than the other aquaporins tested. Overall, these data contribute 
to the discovery and design of selective inhibitors with potential therapeutic application. 
 
 
 
Keywords: aquaporins; permeability; inhibitors; cancer. 
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an IC50 value of (6.64 ± 0.09) µM (n=1). B – Time course 
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course of relative cell volume (V/V0) changes after 
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at pH 5.1. Data are shown as mean ± SEM of ten 
measurements. D – Activation energy for water 
permeability of control and hAQP5 cells. Data are shown 
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Significance levels: *** P < 0.001, ns – nonsignificant, 
compared to the control by student t-test. 
  
55 
Figure 4.24 Top view of human AQP5 monomer structure with 
phosphorylation consensus sites Ser156 localized in 
intracellular loop D and Ser183 and His173 both localized 
in the selectivity filter. As proposed, when His67 side chain 
switches its orientation, it opens the channel, allowing the 
water passage. In such cases, if the proximity of His173 to 
Ser183 is higher than 7 Å and lower than 10 Å, the hAQP5 
monomer shows a wide conformation. Structures were 
generated with Chimera (http://www.cgl.ucsf.edu/chimera) 
and are based on the AQP5 X-ray structure (PDB databank 
code 3D9S). 
  
57 
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levels: **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 
0.05, ns – nonsignificant, compared to the control by 
student t-test. 
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1. Introduction 
1.1.  Importance of water in living cells and discovery of aquaporins 
Water is an important and abundant component for all living cells, where the maintenance 
of water homeostasis is essential to the organisms’ physiological processes [1]–[3]. Over the last 
decades, water exchanges between the inside and outside of the cells have been investigated and 
major advances have been achieved. At first, when lipid bilayer was discovered, investigators 
proposed that water permeability would occur only by simple diffusion through the lipid plasma 
membrane. However, studies in various cell models, as red blood cells (RBCs) [4] suggested that 
water permeability by simple diffusion through the hydrophobic bilayer could not explain the 
high water permeability observed. Therefore, it was proposed the existence of specialized water-
selective channels in the cells’ plasma membranes [3]. Currently, it is well known that water 
crosses the cell membranes by two distinct pathways: partition/diffusion of water molecules 
across the hydrophobic bilayer and single water diffusion through specialized protein channels 
known as aquaporins [5]. Considering that the activation energy (Ea) measures the energy barrier 
to water movement across a membrane, water transport mediated by aquaporins present lower 
values of Ea compared with diffusion through  lipid bilayer [5], [6].   
The first water channel was discovered in erythrocytes’ membrane and was named 
CHIP28; when cloned in oocytes from Xenopus laevis, it induced increased osmotic water 
permeability. When RBCs were incubated with HgCl2, a known potent inhibitor of water channels, 
water permeability decreased and could be restored by incubation with reducing agents [7]. Prior 
to these experiments with CHIP28, the discovery of the effect of these two reagents in RBCs’ 
water permeability was reported by Robert Macey and colleagues that concluded that the water 
channel protein should contain a free sulfhydryl in the pore [3]. Moreover, considering that both 
reagents did not affect water transport across the lipid bilayer, Agre and co-workers concluded 
that CHIP28 protein, presently called as aquaporin-1 (AQP1), was a functional unit of membrane 
water channels [7]. Later, the developed work by Peter Agre and colleagues in this field, was 
recognized with the Chemistry Nobel Prize in 2003.   
1.2.  Aquaporins 
Aquaporins (AQPs) belong to a highly conserved and diversified group of membrane 
proteins called membrane intrinsic proteins (MIPs) that facilitate the transport of water, glycerol 
and other small solutes as urea, ammonia, hydrogen peroxide and carbon dioxide across cell 
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membranes. This family of ubiquitous channel proteins comprise more than 1700 integral 
membrane proteins found in all-living organisms [8]. Therefore, aquaporins have representatives 
in all kingdoms: archaea, eubacteria, fungi, plants and animals [9]. In archaea, it was identified 
an aquaporin-like sequence – AqpM - that showed to be a moderate water channel and a very 
poor glycerol transporter with high thermostability [10]. Various eubacteria possess only one 
orthodox aquaporin and one aquaglyceroporin. For example, Escherichia coli has AQPZ as an 
aquaporin strictly selective for water and one AQP-like sequence, the glycerol facilitator (GlpF) 
[11], [12]. In the case of yeast Saccharomyces cerevisiae, it was identified two orthodox 
aquaporins (ScAqy1 and ScAqy2) and two aquaglyceroporins (YFL054Cp and ScFps1) [13]. 
Also, plant aquaporins show a high multiplicity of isoforms and are divided into four subgroups: 
plasma membrane intrinsic proteins (PIPs), tonoplast intrinsic proteins (TIPs), nodulin-26-like 
intrinsic membrane proteins (NIPs) and small basic intrinsic proteins (SIPs) [14]. Finally, in 
mammalian cells, in particular in human cells, there are 13 aquaporin isoforms (AQP0-12) found 
differentially expressed in organs and tissues that can be divided into three subfamilies:  
(1) classical or orthodox aquaporins (AQP0, AQP1, AQP2, AQP4, AQP5, AQP6, AQP8), 
considered strictly selective to water. However, AQP6 also transports anions as nitrate and AQP8 
transports free radicals as hydrogen peroxide (H2O2); 
(2) aquaglyceroporins (AQP3, AQP7, AQP9, AQP10) that besides water, are also 
permeable to small uncharged molecules, in particular glycerol, and other small solutes;  
(3) S-aquaporins (AQP11, AQP12), also called subcellular aquaporins, that show 
deviations from AQP signature sequence (asparagine-proline-alanine (NPA) boxes that will be 
described below) [15], [16]. AQP11 was recently reported to transport both water and glycerol 
[17] however, AQP12 function is still not clear.  
 
1.2.1. Aquaporins structure and function 
 In 2001, the first AQP1 structure from bovine RBCs was determined by X-ray 
crystallography at a 2.2 Å resolution [18] (Figure 1.1). 
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Figure 1.1: Top view of the extracellular face of an aquaporin-1 (APQ1) homotetramer, with monomers 
labelled from 1 to 4, based on the X-ray structure of bovine AQP1. (Adapted from [19]). 
 
As shown in Figure 1.1, AQP1 is organized as tetramers in membranes where each 
monomer functions as an independent water pore, granting higher selectivity and higher water 
permeation [20]. The arrangement of the 4 monomers creates a central pore that may act as a gas 
(CO2, NO) or a cation channel [21]. Nowadays, more high-resolution structures of AQPs are 
available, allowing to understand the atomic-level mechanisms and enabling their application for 
molecular dynamics simulations and virtual screening [18], [20]. 
Earlier to the identification of AQP1 structure by X-ray crystallography, the studies on 
AQP structure began with electron crystallographic analyses of 2D crystals purified from red 
blood cells [22], with low-resolution, that allowed the comprehension of the general topology of 
AQPs [19]. In 2000, these analyses reached a final density map with a resolution of 3.8 Å that 
was sufficient to build an atomic model for AQP1, revealing for the first time the architecture of 
an AQP water pore [23] (Figure 1.2). 
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Figure 1.2: Topology and three-dimensional structure of an aquaporin protein within the membrane.  
A – Topology structure of an aquaporin within the membrane, representing the six transmembrane helices 
from I to VI and the five loops from A to E. Loops B and E contains the conserved NPA motifs. C represents 
the carboxyl terminus and N represents the amino terminus. B – “Hourglass” three-dimensional structure 
of an aquaporin monomer (a ribbon model of NtAQP1, a PIP1 protein from tobacco) within the membrane. 
The arrows represent short α-helices, that were formed by loop B and E, entering the membrane from the 
extracellular and intracellular surfaces; the two NPA boxes are indicated in green; the six transmembrane 
helices from I to VI are also shown. (Adapted from [9]). 
 
AQPS monomeric units are ≈ 30 kDa [19] and consist of six transmembrane helices (from 
I to VI) and five connecting loops (from A to E), with N- and C-terminal domains located in the 
cytoplasm. Loops A, C and E are extracellular and loops B and D are intracellular. The protein is 
composed of two internal tandem repeats, comprising the amino- and carboxy terminal halves of 
the protein. Each one of the repeats includes three transmembrane helices and a highly conserved 
loop following the second transmembrane helix – loop B and loop E – that include NPA 
sequences, a conserved signature motif. Loops B and E form short α-helices (HB and HE) that 
folds back into the membrane, with loop B entering the membrane from the cytoplasmic side and 
loop E from the extracellular side. The NPA boxes are orientated in 180 degrees to each other, 
creating an aqueous pathway through the aquaporin pore as proposed in the hourglass model [9] 
(Figure 1.2B).  
This hourglass-shaped structure of AQPs has an extracellular and a cytoplasmic vestibule 
where water molecules are presented to be permeated through a central amphipathic pore region 
of 20-25 Å, that connects the two vestibules. In AQPs amphipathic pore, two-stage filters 
responsible for high selectivity to water and glycerol permeation are found: one corresponding to 
the NPA motifs interaction at the membrane centre, that generates an electrostatic barrier for 
proton exclusion, and a selectivity filter located approximately 10 Å away from these motifs [24]. 
This selectivity filter is also known as the aromatic/arginine (ar/R) constriction, because it is 
composed by conserved aromatic and arginine residues [18]. It is located at the narrowest point 
A B 
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of the channels, being formed by three (in aquaglyceroporins) or four (in orthodox aquaporins) 
residues that determine the size of molecules allowed to be permeated, distinguishing features 
that identify the aquaporins subfamilies [23], [25], [26].   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3 – AQP1 selectivity filter, important amino acid residues and water molecules forming the 
hydrophilic face of the channel pore. Cut-away side view of the channel with secondary structure shown in 
ribbon format. Side chains critical to establishing the hydrophilic path across the length of the selectivity 
filter are shown. The four water molecules located within the selectivity filter are represented as green 
spheres. Of these four water molecules only the middle two are close enough to form a hydrogen bond 
between water molecules. The constriction region and NPA motifs are indicated by light blue and black 
arrows, respectively. (Adapted from [18]). 
 
AQPs strictly prevent the conduction of protons through the pore, being highly selective 
to water or glycerol transport.  The mechanism for proton exclusion was proposed by Murata and 
co-workers from the AQP1 structure obtained by electron crystallography [23]. Loops B and E 
are held together by Van der Waals interactions between the proline residues of the NPA motifs, 
close to the centre of the pore. On the other hand, the two asparagine residues of the NPA motifs 
(Asn76 and Asn192) are held tightly in position and extend their polar side chain residues into 
the pore. Due to the positive electrostatic field generated by the dipole moments of the pore 
helices, a water molecule approaches the pore centre and orients itself to the side of NPA motifs 
to allow the oxygen atom form hydrogen bonds with the amine groups of the two asparagine 
residues [22], [23] (Figure 1.4A e 1.4B). Consequently, the two hydrogen atoms from the water 
molecule are oriented perpendicular to the pore axis, preventing the formation of hydrogen bonds 
with the adjacent water molecules (Figure 1.4C). Therefore, the water molecule can only form 
hydrogen bonds to the NPA motifs by the oxygen atom while the hydrogen atoms can only 
establish hydrogen bonds outwards the centre of the pore and towards the extracellular and 
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cytoplasmic pore entrance. Thus, NPA motifs are essential to compensate the energy cost of 
dehydration by replacing the interactions from the solvent, and to establish a pathway for 
coordinating water transport (or glycerol in aquaglyceroporins), guaranteeing the blockage of the 
protons permeation [18], [19], [23], [24]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: Representation of the mechanism for water permeation and blockage of proton transport of 
AQP1. A – Representation of how the partial charges from the short helices’ dipoles reorient the water 
molecules passing through the constriction of the pore. B and C – Representation of the hydrogen bonding 
of the oxygen atom of the water molecule to the amide groups of Asn76 and Asn192. (Adapted from [23]). 
 
 The ar/R constriction region in AQP1 is located at the beginning of 20 Å long selectivity 
filter. At the constriction region, residues His182 and Arg197, along with the accessible carbonyl 
oxygen of residue Cys189, compose the hydrophilic face of the pore. The imidazole ring of 
His182 is extended into the pore while Arg197 is pointed upwards, parallel to the pore axis [18]. 
Concerning Cys189, it is the site for blockage of AQP1 by HgCl2. Its side chain extends to the 
pore from the extracellular side of the constriction region, suggesting that inhibition by this 
mercury compound results in physical blockage of the water transport. Opposite to the hydrophilic 
face, there is the hydrophobic face where Phe58 is located. Therefore, ar/R constriction region in 
AQP1 is formed by Arg197, His182, Phe58 and Cys189 being the first three residues highly 
conserved across water-specific aquaporins. This region corresponds to the narrowest point of the 
pore with a 3 Å diameter that limits the size of substrates allowed to permeate the pore, which is 
A 
B C 
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only slightly larger than the 2.8 Å diameter of a water molecule [22]. Therefore, the pore 
constriction prevents permeation of all molecules bigger than water, including hydrated ions. For 
aquaglyceroporins, in the case of GlpF, His182 is replaced by glycine that provides additional 
room to Cys191 be replaced by phenylalanine. These two substitutions increase the size and 
hydrophobicity of the GlpF constriction region, allowing simultaneously the transport of glycerol 
and the low permeability to water [24]. 
1.2.2. Localization, biological functions of aquaporins and associated 
pathologies 
 AQPs are widely expressed in the body, especially in tissues that involve fluid transport 
since their function is to facilitate the water and glycerol transport through the plasma membrane. 
Therefore, these channels are involved in many physiological processes in epithelia, central 
nervous system, epidermis, adipocytes, collecting duct of kidney, among others [9], [19], [27]. 
Studies of phenotypes of AQP-knockout mice have provided information about the AQP 
physiology and, consequently, of the pathologies associated, being also relevant for the discovery 
of potential AQP modulators. Below, data from AQP-knockout mice studies are discussed for the 
main aquaporins’ physiological functions, especially detailed for the aquaporins under study in 
this work: AQP1, AQP3, AQP5, AQP7 and AQP9. 
1.2.2.1. Transepithelial water transport 
 AQPs facilitate transepithelial water transport in the kidneys, in response to osmotic 
gradients created by transport of active ions and neutral solutes. AQP1 is expressed in the apical 
and basolateral membrane of the renal proximal tubule and the thin descending limb of Henle, as 
well as in the endothelial cells of descending vasa recta. Studies with mice deficient in AQP1 
revealed the reduced water permeability leading to the impairment of the water reabsorption in 
the renal proximal tubule and of the renal count-current multiplication in descending limb of 
Henle and vasa recta. Therefore, AQP1-knockout mice are unable to concentrate urine leading to 
water diuresis, enhancing the important role of this aquaporin in the renal urinary concentrating 
mechanism [19], [28]. Moreover, this defects in urine concentration when AQP1 is not being 
expressed are unlikely to affect NaCl and urea permeabilities since AQP1 does not permeate these 
solutes, suggesting that the water diuresis is just a result of water permeability depletion [29].  
Aquaporin-2 (AQP2), aquaporin-3 (AQP3) and aquaporin-4 (AQP4) are located in the 
kidney collecting duct epithelial cells: AQP2 is expressed in the apical membrane and intracellular 
vesicles and AQP3 and AQP4 are expressed in the basolateral membrane [30]. For an effective 
water reabsorption, kidney cells from the collecting duct require a high transepithelial 
permeability to water that is attained by the constitutively active AQP3 and AQP4 in basolateral 
cell membrane and also by the vasopressin-induced trafficking of AQP2 from intracellular 
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vesicles to the apical cell membrane [19]. In mice deficient of AQP2, AQP3 and AQP4, the urine 
concentration is impaired in the collecting duct, being expected that potential modulators of these 
AQPs would present a similar effect, such as the vasopressin V2 receptor antagonists that can 
regulate AQP2 expression [31]. Mutations in AQP2 that interfere with its folding and cellular 
processing and/or its intrinsic water function, are often associated with nephrogenic diabetes 
insipidus (NDI), one of the known aquaporinopathies, which demonstrates the essential role of 
this aquaporin in the urine concentrating mechanism [32]. NDI, a hereditary disease, is 
characterized by polydipsia and polyuria, being the latter the main cause for the death of mutant 
neonatal mice since it induces renal failure [33].  
Aquaporin-5 (AQP5) is expressed at the luminal membrane of serous epithelial cells in 
submucosal glands in nasopharynx and upper airways. Data from knockout-mice lacking AQP5 
studies suggest that this aquaporin facilitates fluid secretion in submucosal glands meaning that 
its modulation could alter the gland secretions in cystic fibrosis or in other airway diseases [34].  
 Moreover, AQP1 is expressed in the apical membrane of the choroid plexus epithelium 
(CPE), being important to facilitate the water transport across the CPE membrane during the 
secretion of cerebrospinal fluid (CSF). Mice lacking AQP1 present a lower osmotic permeability 
that produce a significant reduction in CPE permeability and in CSF production. Consequently, 
the intercranial pressure decreases, suggesting that discovery of novel AQP1 inhibitors would be 
important to treat elevated intercranial pressure [35]. Furthermore, this aquaporin is also 
expressed in ciliary epithelium in the eye and data from AQP1-knockout mice revealed the 
decrease in aqueous fluid production and in intraocular pressure, suggesting that AQP1 inhibitors 
would be important to treat elevated intraocular pressure in diseases as glaucoma [36]. 
1.2.2.2.  Central nervous systems – brain swelling, epilepsy and NMO 
 Aquaporin-4 (AQP4) is most abundant in astrocytes and ependymal-cerebrospinal fluid 
barrier, with its highest expression on the astrocytes end-feet that surround blood vessels in the 
central nervous system (CNS), being responsible for the control of the bidirectional fluid 
exchange [37], [38]. Studies with AQP4-null mice revealed the role of AQP4 in regulation of the 
water flux across the blood-brain barrier being involved in: water uptake into brain tissue in 
cytotoxic edema [39], [40] (water moves into the brain through an intact blood–brain barrier); 
water clearance after vasogenic edema [41] (water moves into the brain by bulk fluid flow through 
a leaky blood-brain barrier [27]); absorption of cerebrospinal fluid in hydrocephalus [42] and a 
novel therapeutic target for control of seizures, in particular, for epilepsy, since AQP4 knockout 
mice increase the seizure duration with increment in extracellular space volume [43]. Besides the 
pathophysiological functions already mentioned, this orthodox aquaporin is also implicated in 
neuroinflammation. Neuromyelities optica (NMO) is an autoimmune inflammatory 
demyelinating disease of CNS that affects optic nerves and spinal cord, associated with 
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autoantibodies against AQP4, the target antigen [27], [37], [44].  Also, about 50% of patients lose 
vision in at least one eye or are unable to walk independently [45]. The binding of AQP4-IgG to 
AQP4 in astrocyte end-feet activates the complement, leading to the primary astrocyte injury. 
After this lesion, inflammatory cells are recruited which further cause the blood-brain barrier 
disruption. The astrocyte loss and inflammation lead to demyelination of oligodendrocytes and 
neuron loss. Current NMO treatments include general immunosuppression, immunomodulation 
and plasma exchange [46]. 
1.2.2.3.  Tumor – cell migration, proliferation and angiogenesis 
 Considering that the aim of this work is focused on the role of AQPs overexpression in 
cancer, their implication in this disease will be described in more detail in this chapter and 
especially focused for the aquaporins under study: AQP1, AQP3, AQP5, AQP7 and AQP9.  
 Cancer is known to be the second leading cause of mortality and is estimated to account 
for 9.6 million death in 2018. It is characterized by the growth of abnormal cells that have the 
ability to invade surrounding tissue and spread throughout the body [47]. As a result of the major 
progress for the comprehension of this disease, treatment has evolved for the past decades, 
improving cancer survival. Still, much more advances are needed in this field in terms of efficacy 
and improving life quality, since the therapies available are very toxic and lack effectiveness [48]. 
Therefore, it is essential to find new possible therapeutic targets. Considering that aquaporins are 
overexpressed in several types of cancer tissues, they could be potential drug targets to discover 
new cancer therapies.  
 AQP1 is highly expressed in vascular endothelial cells [49] in several different tumor cell 
types (as brain, breast colorectal, lung, ovarian, among others) [50] where it increases the 
membrane water permeability. Saadoun et al. reported that mice lacking AQP1 have reduced 
angiogenesis in vivo, leading to reduced tumor growth and extensive tumor necrosis [51]. 
Additionally, it was found evidences that AQP1 is involved in cell migration, revealing that 
AQP1-expressing tumors increase their  invasiveness and their ability to metastasize by crossing 
microvascular endothelial barriers [51], [52]. It has been proposed a mechanism for AQPs in cell 
migration that involves a series of cellular events: first, AQPs are polarized on the front edge of 
cell protrusions (lamellipodium) in migrating cells, that combined with actin cleavage and the ion 
uptake at the tip of lamellipodium, creates osmotic gradients leading to the influx of water across 
the cell membrane. This causes the increase of the local hydrostatic pressure, inducing the 
expansion of the lamellipodium, which can create space for actin polymerization and aquaporin-
dependent cell migration (Figure 1.5). Therefore, this suggests that AQPs mediate the rapid 
changes in cell shape when migrating cells squeeze through the extracellular matrix, since these 
cell changes demand rapid water fluxes that can only be performed in the presence of aquaporins.  
This explains the need of overexpression of AQPs in tumor cells, increasing the invasion and 
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metastasis to local tissue. Accordingly, several in vitro and in vivo assays have confirmed a 
decreased ability of cells to migrate when AQP1 is not being expressed [50]–[53]. 
 
 
Figure 1.5 - Proposed mechanism of AQP-dependent cell migration, showing water influx through AQP 
at the tip of a lamellipodium. (Adapted from [30]). 
  
AQP5 is expressed in the epithelial cells of secretory tissues [54], being upregulated in 
various tumors such as lung, colon and breast tumors, among others [50]. In the case of lung 
adenocarcinomas, AQP5 is highly expressed at the apical membrane of the alveolar type I cells, 
strongly increasing water permeability, with potential for local invasiveness and metastasis ( 
normally at lymph nodes) [55], [56].  When AQP5 gene is silenced, migration and invasion are 
decreased, indicating that AQP5 plays an important role in the development of lung 
adenocarcinoma. AQP5 is also overexpressed in the ductal epithelial cells of human breast cancer 
tissues, normally associated with invasive carcinoma with lymph node metastasis. The highly 
expression of AQP5 in these cells, propose its essential role in the tumorigenesis, cancer 
proliferation and migration. These processes are strongly reduced when the AQP5 expression is 
decreased. Furthermore, Jung et al. suggested that the alterations in osmolarity conditions of the 
tumor microenvironment could be related to the progression of breast cancer through cell 
proliferation and migration [57]. Additionally, AQP5 is upregulated in the membrane of gastric 
carcinoma cells, being also overexpressed in lymph node metastasis. This upregulation leads to 
an increased water permeability that conducts to enhanced metastatic potential and increment of 
cell proliferation and migration, as in the other tumors mentioned [54]. 
 Aquaporin-3 (AQP3) is an aquaglyceroporin expressed at the basolateral membrane of 
epithelial cells in kidney collecting duct, airways, intestine, urinary bladder, conjunctiva, cornea, 
among others. AQP3, in mammalian skin, is expressed in keratinocytes residing in the plasma 
membranes of the basal epidermal cell layer, being overexpressed in skin tumors [50], [58]. Hara-
Chikuma and Verkman reported that AQP3-null mice are resistant to the formation of skin tumors, 
probably as a result of the impairment of glycerol uptake by tumor cells, with absence of 
papillomas. Furthermore, this deletion and reduced glycerol content leads to the decrease of 
intracellular ATP, suggesting that glycerol is the key regulator of ATP. For this reason, AQP3-
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facilitated glycerol transport is essential for the growth and survival of tumor cells, being glycerol 
the main energy source for its deregulated metabolism [50], [58], [59].  
 Aquaporin-7 (AQP7) is expressed in the plasma membranes of normal ovarian epithelium 
and of benign tumor cells and nuclear membrane of borderline and malignant tumor cells whereas 
AQP9 is expressed in the basolateral membranes of ovarian benign and borderline tumor cells 
and throughout the plasma membranes of malignant cells. Yang and co-workers showed that both 
AQP7 and AQP9 expression is higher in malignant tumors, indicating their role in energy 
metabolism in ovarian epithelial tumors and in ovarian carcinogenesis [60].  
 Aquaporin-9 (AQP9) is uniformly distributed in the surface of the astrocytes, being 
localized at the border of the cerebrospinal fluid spaces and responsible for brain water 
homeostasis. During ischemia and in malignant gliomas, the lactate permeability of AQP9 
increases as a response to lactate acidosis, resulting in glycerol and lactate clearance from the 
extracellular space [61]. Moreover, unlike the other cases described, AQP9 was reported to be 
down regulated in hepatocellular carcinoma, being localized in the basolateral membrane of 
hepatocytes in the liver. This aquaglyceroporin when overexpressed in these tissues, conducts to 
the decrease in invasion and migration of the tumor cells, preventing the tumor growth and 
metastasis [62].  
 
Figure 1.6 – Overexpression of aquaporins in various types of cancer: brain, lung, liver, colorectal and 
breast. (Adapted from [63]). 
 
1.2.2.4.  Aquaglyceroporins functions 
Besides their role in the energy metabolism and progression of the tumor, there are other 
functions associated to aquaglyceroporins. Due to their broad pathophysiological functions 
already reported, the aquaglyceroporins under study (AQP3, AQP7 and AQP9) will be 
specifically discussed in this chapter.  
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As already mentioned, AQP3 is expressed in keratinocytes localized in the basolateral 
layer of the epidermis. By acting as a water-retaining “humectant”, glycerol is essential to 
preserve the skin moisture. Studies with mice lacking AQP3 showed reduction of the glycerol 
content, leading to a decrease in stratum corneum (SC) hydration and, consequently, a decrease 
in skin elasticity. With glycerol replacement, the skin hydration and elasticity were restored, as 
well as barrier properties, evidencing the involvement of AQP3 in skin physiology [64], [65].  
Moreover, AQP3-null mice have shown defective wound healing, that involves the impairment 
of cell proliferation and migration. As a result of AQP3-facilitated water transport, cell migration 
is accelerated while glycerol transport via AQP3 is required in cell proliferation [66].  
Moreover, AQP3 is strongly expressed at the basolateral membrane of colonic epithelial 
cells. When mice have colitis and are not expressing AQP3, the colonic epithelial cells 
proliferation is impaired and is restored after glycerol supplementation, improving the survival 
and reducing the severity of colitis [67]. AQP3 is also localized in peritoneal macrophages being 
involved in the  water and glycerol transport through the membrane in macrophage phagocytosis 
and migration [68]. 
AQP7 is expressed in adipocytes and AQP9 is expressed in hepatocytes, being both 
involved in the adipose metabolism. Hara-Chikuma and co-workers reported that AQP7-null mice 
had reduced adipocyte glycerol permeability, resulting in the intracellularly increase of glycerol 
and consequently, triglycerides accumulation and adipocyte hypertrophy [69]. Thus, it is 
proposed that AQP7 is responsible for the secretion and uptake of glycerol from the adipocyte. 
When AQP7 is downregulated, triglycerides start to accumulate, resulting in the development of 
obesity and could also result in higher concentrations of insulin due to the increase of intracellular 
glycerol [70]. About AQP9, it is responsible for hepatic uptake of glycerol and may be associated 
with the development of diabetes in terms of glycerol and glucose metabolism. In AQP9-
defficient mice, levels of glycerol and triglycerides are increased and since AQP9 is not being 
expressed, glycerol cannot enter the cell and consequently, hepatic gluconeogenesis is impaired. 
This implies that glucose is not being produced and so, with glycerol oral administration, the 
levels of glycerol and triglycerides return to normal, enabling the production of glucose [71]. 
1.2.2.5. Peroxiporins and their role in cancer 
Recent evidences showed that some AQPs can transport H2O2, called peroxiporins. H2O2 
is a major redox metabolite, present in all aerobic organism, that intervenes in redox sensing, 
signalling and redox regulation [72]. It belongs to the reactive oxygen species (ROS) and when 
their production is imbalanced, it results in oxidative stress in the cells, causing cell damage, 
namely in lipids, proteins DNA, and even cell death, playing a key role in cancer development 
[73]–[75]. In particular, the permanent modification of DNA by oxidative damage is a critical 
step in mutagenesis and consequently, leads to carcinogenesis. On the other hand, H2O2 is an 
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important intracellular signalling molecule. Recent studies have reported that redox-dependent 
signalling is also essential to multiple cell processes such as differentiation and growth and can 
act as second messengers in immune cells, being involved in autophagy and mitophagy [75] and 
in cancer cells apoptosis. In addition to the participation in many cell processes, ROS are 
responsible for triggering cellular defense mechanisms that end up as a long-term protective shield 
[76]. Therefore, H2O2 has a dual effect wherein at intracellular concentrations below toxic levels, 
it functions as a second messenger in homeostatic redox signalling, designated as oxidative 
eustress. At higher concentrations, hydrogen peroxide leads to adaptive stress responses being 
involved in biomolecules’ damage and designated as oxidative distress [72]. The regulation of 
these processes is maintained by multiple intracellular redox-regulating molecules such as 
thioredoxins that have cysteine residues for which H2O2 is highly reactive [73], [74]. For this 
redox regulation, aquaporins also play an important role since they control the passage of H2O2 
through the membrane and thus, control H2O2 intracellular concentration. Currently, the 
aquaporins that are known to permeate hydrogen peroxide are: AQP3, AQP5, AQP8, AQP9 and 
probably also AQP11. Recent studies suggested that some aquaporins are able to transport NOX-
derived H2O2, affecting redox signalling pathways mediated by hydrogen peroxide, being 
associated with leukaemia cell proliferation [77].  
In our lab, it was recently studied the transport of hydrogen peroxide for AQP5 that plays 
a crucial role in cancer. Accordingly, AQP5 has been reported to be overexpressed in cancer cells 
and tumor tissues, suggesting its implication in tumor formation, cell migration, proliferation and 
adhesion to human cancer [78]. Likewise, it is hypothesized that this upregulation is due to the 
ability of AQP5 to permeate H2O2 besides water, that are essential for the cancer progression [73], 
[79]. In addition, AQP5 is found preferentially phosphorylated in tumor cells by cAMP-dependent 
phosphorylation through PKA, that regulate the expression and trafficking of this aquaporin. 
When there is a short exposure to cAMP, it results in AQP5 internalization from the plasma 
membrane while in a long exposure to this molecule, AQP5 is translocated to the plasma 
membrane, being abundantly expressed [78], [80]. Furthermore, Woo et. al showed that 
phosphorylation of the PKA consensus site – Ser156 – on AQP5, activates the Ras signalling 
pathway increasing cell proliferation [81], [82]. Moreover, AQP5 can change between open and 
closed state by a tap-like mechanism caused by the translation of His67 in the cytoplasmic end. 
Also, when in the open state, the selectivity filter regulates the passage of water molecules by two 
conformations: wide and narrow. When His173 is close to Ser183, the channel is in the narrow 
conformation, restricting the water passage. In the wide state, the two residues are far from each 
other, allowing the passage of water molecules. Moreover, by rAQP5 studies in our lab, it was 
showed that AQP5 phosphorylation along with deprotonation of His183 residue at pH 7.4, leads 
to the widening of the pore. Therefore, AQP5 might be regulated by pH dependent on 
phosphorylation and might  also be involved in cell oxidative stress response [79]. In this work, 
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considering what is already known about AQP5 trafficking and expression regulation, human 
AQP5 regulation by phosphorylation and pH was assessed, unveiling the important residues for 
water permeation. 
1.2.3. Aquaporin inhibitors 
Considering the numerous physiological functions of aquaporins and the pathologies 
associated, AQPs have shown their great potential as drug targets for various diseases, including 
cancer. However, the identification of AQP modulators for therapeutic and diagnosis purposes 
has revealed to be challenging. Until now, four classes of AQP-targeted small molecules have 
been reported: (1) heavy metal-based inhibitors; (2) small molecules that are reported to inhibit 
water conductance; (3) small-molecules targeting the interaction between AQP4 and NMO 
autoantibody; and (4) agents that act as chemical chaperones to facilitate the cellular processing 
of NDI-causing AQP2 mutants [25], [50]. However, most of them show severe side effects due 
to the lack of selectivity, low efficiency and bioavailability. Therefore, there is an emergent need 
to find potent and selective aquaporin inhibitors with minimum toxicity, that could be applied to 
cancer therapeutics. This chapter will be focused on the most promising inhibitors identified until 
now for the aquaporins of interest (AQP1, AQP3, AQP5, AQP7 and AQP9), consisting in heavy-
metal and small molecule inhibitors. It will be given special emphasis to polyoxometalates, 
compounds of vanadium, copper, zinc and gold, that were tested in this work as potential AQP 
inhibitors. 
1.2.3.1. Heavy metal inhibitors 
It is known that AQPs can be regulated by various factors, including protein 
phosphorylation, pH and metal ions, such as divalent transition metal cations [50]. This group of 
metals has been studied to assess their possible effects on aquaporins permeability. Ni2+ (NiCl2) 
was reported to inhibit water permeability in AQP3 in lung epithelial cells. Later, it was found 
that both Ni2+ and Cu2+ (CuSO4) inhibited glycerol and water permeability of AQP3 and 
Pb2+(Pb(CH3COO)) and Zn
2+ (ZnCl2) had no effect on AQP3 permeability [83]. Ni
2+ and Cu2+ 
bind to extracellular amino acid residues of AQP3 as Ser152, responsible for their effect in the 
aquaporin.  
Mercurial compounds as HgCl2 have been widely applied in aquaporin assays to assess 
their function, since mercury strongly inhibits these channels. The mechanism of inhibition 
consists of Hg2+ ions binding to AQPs cysteine residues. For AQP1, mercury binds to Cys189, 
located in the ar/R constriction region, preventing the passage of water molecules. These 
mercurial compounds are known to be very toxic due to their non-specificity and thus, are  not 
suitable for therapeutic applications [50].  
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Furthermore, silver compounds have been tested as possible aquaporin inhibitors. In fact, 
silver nitrate and silver sulfadiazine were tested in RBCs and led to a rapid and irreversible 
inhibition of AQP1. These silver compounds showed to be more potent inhibitors than mercury 
compounds [84], [85]. 
The compounds tested throughout this work were all composed by heavy metals. The 
screened polyoxometalates, vanadium, copper, zinc and gold-based compounds will be addressed 
below. 
1.2.3.1.1. Polyoxometalates 
Polyoxometalates (POMs) are clusters of transition metal (W, Mo, V, Nb) and oxygen 
atoms. These compounds exhibit diverse sizes and structures with multiple properties and 
functions that are applied in catalysis, nanoscience, macromolecular crystallography and 
medicine. POMs have been reported as promising anticancer drug candidates however, they 
exhibit high toxicity and low selectivity. In this work, it was tested polyoxotungstates (POTs) and 
polyoxovanadates (POVs), where the latter ones have been described as more active than POTs 
in terms of antitumoral activity [86]. Their inhibitory effect was evaluated in aquaporins in order 
to predict their role in cancer and because they were reported as inhibitors of ATPases activity, 
that are membrane proteins just as aquaporins. The interest in POMs has been increasing due to 
their capacity in interacting with important enzymes including alkaline phosphatases, ecto-
nucleotidases and ATPases and also due to their potential to interfere with cellular processes such 
as mitochondria respiration. Gumerova and colleagues identified POTs as potential inhibitors of 
P-type ATPases, namely Ca2+-ATPase and Na+/K+ ATPase [87], where P2W18 presented the 
highest inhibitory activity for Na+/K+ ATPase with 100% inhibition at 10 µM and the second 
highest for Ca2+-ATPase with an IC50 value of 0.6 µM. Moreover, some polyoxovanadates have 
exhibited high inhibitory effect on Na+/K+ ATPase and Ca2+-ATPase [88], [89] . In addition, 
Bijelic et al. highlighted the importance of the functionalization of POMs with organic groups or 
the use of nanoparticles for delivery to try to mitigate the toxic effects and the lack of cell 
penetration, obtaining compounds with anticancer properties, suitable for therapeutic application. 
1.2.3.1.2. Vanadium, copper and zinc compounds 
Vanadium is a metal of high physiological, environmental and industrial importance and 
for the last years, vanadium compounds have been investigated for their potential as therapeutic 
agents for the treatment of malignancies. It appears that this metal reduces growth and spread of 
tumors through inhibition of tumor cell proliferation and metastasis and by inducing apoptosis 
and autophagy [90]. Therefore, vanadium shows potential to be an anticancer metallodrug and 
consequently, arouses the interest of evaluating its inhibitory effect on aquaporins permeability.  
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Copper is found in all living organisms and is important for the function of various 
enzymes and proteins in energy metabolism, respiration and DNA synthesis, which includes 
cytochrome oxidase, superoxide dismutase, ascorbate oxidase and tyrosinase. The main function 
of this metal involves redox reactions where it reacts directly with oxygen to produce free radicals 
and for that reason, it is tightly regulated, preventing possible toxic effect.  Until now, various 
copper complexes have been studied for their potential antitumor activity [91]. As already 
mentioned above, copper has been reported as an aquaporin inhibitor, specifically for AQP3 [84]. 
Moreover, Ana Paula Martins and colleagues reported Cuphen inhibition of AQP3 with an IC50 
value of (81.9 ± 4.1) µM that is particularly high, suggesting an inhibitory effect with low efficacy 
[92]. Also, Yukutake and co-workers described Cu2+ as an AQP4 inhibitor via Cys178 with an 
IC50 value of (7.7 ± 2.5) µM [93]. 
Zinc is an important cytotoxic/tumor suppressor agent in various types of cancer. When 
zinc is present in malignant cells, it has a cytotoxic effect leading to altered metabolic effects or 
inhibition of growth/proliferation and of invasion/migration. Therefore, this metal displays great 
antitumor activity [94]. As previously mentioned, studies with Zn2+ showed its lack of potency 
for AQP3 inhibition, however Yukutake and co-workers found that zinc can inhibit AQP4 
expressed in proteoliposomes in a rapid and reversible way by bonding with low efficacy to 
Cys178 (IC50 value of (287 ± 58.5) µM) [93].  
 
1.2.3.1.3. Gold-based compounds 
Recently, coordination gold(III) compounds have been identified as selective and 
effective aquaglyceroporin inhibitors. Our lab reported a potent and selective inhibitor of AQP3 
by a water-soluble gold(III) coordination compound – [Au(phen)Cl2]Cl (phen = 1,10 – 
phenanthroline, Auphen) (Figure 1.7) [95], [96] . Auphen inhibited AQP3 glycerol permeability 
in erythrocytes with an IC50 value of (0.8 ± 0.08) µM, while having a modest inhibitory effect on 
AQP1 water permeability [96]. Moreover, Auphen’s capacity in inhibiting cell proliferation in 
multiple cell lines with different levels of AQP3 expression was reported [97], corroborating the 
results for AQP3 inhibition in RBCs. To understand the binding sites of Au(III) to AQP3, a 
homology model of human AQP3 was built and compared to the structure of human AQP1, 
enabling the identification and characterization of protein binding pockets. It is known that 
Au(III) ions interact with sulphur-donor groups of proteins such as the thiolate of cysteine or the 
thioether of methionine residues. In the case of AQP1, there is no cysteine, methionine or histidine 
residue accessible for gold binding, whereas thiol group of Cys40 of AQP3 is projected towards 
the extracellular space, approaching the channel pore. Therefore, it appears that this residue is the 
binding site for Auphen and other Au(III) compounds, being able to block the channel, preventing 
the passage of glycerol via AQP3 [96]. Moreover, after incubation with Auphen, the AQP3 
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activity can be recovered by addition of a reducing agent, 2-mercaptoethanol. Other Au(III) 
compounds were also tested for their glycerol transport inhibition in human RBCs being the most 
promising ones Aubipy and Auterpy [92] (Figure 1.7). 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7: Gold(III) coordination compounds as inhibitors of aquaglyceroporins. (Adapted from [25]). 
  
Both Aubipy and Auterpy were very effective in inhibiting the glycerol transport of AQP3 
with IC50 values of (2.3 ± 0.7) µM and (1.0 ± 0.2) µM, respectively, being similar to Auphen in 
terms of potency and also in terms of reversible binding to Cys40 [92]. Due to these promising 
results, Auphen has revealed to be the most potent gold(III) compound in inhibiting AQP3 and 
for that reason, it was tested in another aquaglyceroporin, AQP7, expressed in adipocytes to assess 
the selectivity of this compound. Adipocytes treated with 15 µM Auphen showed a decrease on 
water and glycerol permeability of 63% and 79%, respectively. Through docking studies, it was 
found that Auphen binds close to the constriction pore and interacts with the sulphur atom of 
Met47 through its gold(III) centre [25], [98]. Therefore, Auphen is able to inhibit both AQP3 and 
AQP7 with great potency by binding to sulphur groups of certain residues, with the advantage of 
being non-toxic for the cells [96]. 
1.2.3.2.  Small molecules inhibitors 
 Tetraethylammonium (TEA) was identified as an inhibitor of human AQP1 expressed in 
Xenopus oocytes, and acetazolamide, a carbonic anhydrase inhibitor, induced a reduction of water 
permeability in rat AQP1. However, it was discovered later that they did not inhibit AQP1 water 
permeability in RBCs [99]. In fact, Esteva-Font and co-workers tested the proposed 12 potential 
AQP1 inhibitors (at 50 µM) and did not find any significant water transport inhibition. Therefore, 
they suggested that no small molecules inhibitors actually have the capacity of affecting AQP, 
meaning that , until now, the heavy metal-based compounds are the only ones reported as good 
AQP1 inhibitors [100] . 
 Phloretin is a non-specific aquaglyceroporin inhibitor, being capable of inhibiting AQP3, 
AQP9 and the urea transporter (UT-A1). Treatment with 100 µM of phloretin leads to an AQP9 
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inhibition of 86% when expressed in Xenopus oocytes and treatment with 500 µM phloretin 
produces an AQP3 inhibition of 83% in proteoliposomes [84].  
 A new set of aquaglyceroporin inhibitors has been identified with special highlight for 
DFP00173 and Z433927330. The first one selectively inhibited AQP3 with slight inhibition of 
AQP7 and AQP9 and Z433927330 strongly inhibited AQP7 with low AQP3 and AQP9 inhibition. 
In terms of inhibition of AQP3 permeability in erythrocytes, DFP00173 and Z433927330 
exhibited an IC50 value of 0.2 µM and 0.6 µM, respectively. In Chinese hamster ovary (CHO) 
cells expressing these three aquaglyceroporins, DFP00173 selectively inhibited AQP3 with an 
IC50 value of 0.1 µM while Z433927330 selectively inhibited AQP7 (IC50 ≈ 0.2 µM) with lower 
inhibition of AQP3 (IC50 ≈ 0.7 µM) and AQP9 (IC50 ≈ 1.1 µM) [84], [101].  
Overall, few drug structures were identified so far as selective AQPs inhibitors. New 
molecules with potency and selectivity to modulate individual AQPs are urgently needed, to foster 
research and development of new cancer therapeutics. 
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2. Thesis aims 
 
In this project, the first aim is the screening of compounds as aquaporin modulators using 
as experimental models’ human RBCs and yeast cells transformed with plasmid encoding human 
aquaporins.  
The compounds will be first tested in RBCs that endogenously express AQP1 and AQP3 
that are water and glycerol channels, respectively. Interestingly, AQP1, AQP3 and AQP5 are the 
AQPs isoforms most overexpressed in cancer tissues.  
The inhibitory effect of these compounds in RBCs will be assessed by performing 
membrane water and glycerol permeability assays using the light scattering stopped-flow 
technique, already optimized and currently in use in our lab. Using this screening cell system, the 
inhibitory potency (IC50), reversibility and selectivity will be evaluated for the compounds of 
interest. Their inhibitory potency and selectivity will then be validated in yeast cells devoid of 
endogenous aquaporins (aqy-null) and transformed with plasmid encoding individual human 
AQP isoforms, being an excellent tool to validate inhibitors selectivity. In this case, membrane 
permeability will be assayed in transformed yeasts loaded with a volume sensitive fluorophore, 
by a fluorescence stopped-flow technique. Overall, the data from these studies will contribute for 
the discovery of potent and selective AQP inhibitors with potential application for cancer 
therapeutics. 
Moreover, knowing that AQP5 is overexpressed in cancer and so far with no inhibitors 
identified, mechanism of AQP5 permeation will be investigated by mutagenesis studies and 
permeability assays, to identify the residues responsible for permeability further contributing to 
the design of new drugs.  
Using the optimized stopped-flow technique, the functional characterization of aquaporins 
from various organisms with unknown activity (eucalyptus, rice, potato, tardigrade, Methanocella 
conradii, Kyrpidia tusciae, Methanothermobacter thermautotrophicus and Novibacillus 
thermophilus) will also be performed to ascertain their activity. 
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3. Materials and Methods 
3.1 Compounds preparation 
3.1.1. Polyoxometalates 
The polyoxometalates (POMs) of vanadium and tungstate were sent by a collaborator 
from Faculty of Sciences and Technology of the University of Algarve, already in solution. Their 
molecular and anion formulas are summarized in the following table (Table 3.1). 
Table 3.1: Compounds and respective anions formula and the location where the polyoxometalates were 
synthetized. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The POMs marked as 1, 3, 4, 5, 6 and 7 were sent at a concentration of 1 mM which was 
the concentration used in the performed experiments. The ones marked as A, B, C, E and F were 
sent at a concentration of 5 mM that were then diluted to 1 mM in Milli Q water to be used in the 
stopped-flow experiments. Since compound B, E and F were not totally soluble, they were 
sonicated (1 cycle for 15 minutes except for E that was sonicated and heated by bath at 30ºC 
multiple times). 
Compound Molecular formula Anion 
1 K12[α-H2P2W12O48].24H2O P2W12O48 
3 Na6[TeW6O24].22H2O TeW6O24 
4 NH4VO3 pH 4.0 V10O28 
5 NH4VO3 pH 8.48 VO4 
6 K3MnV11O30 MnV11O30
3- 
7 K7MnV13O33 MnV13O33
7- 
A K6[α-P2W18O62].14H2O P2W18 
B K10[α-P2W17O61].20H2O P2W17 
C Na12[α-P2W15O56].24H2O P2W15 
E K28Li5H7[P8W48O184].16H2O P8W48 
F (NH4)14[NaP5W30O110].31H2O P5W30 
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3.1.2. Vanadium, copper and zinc compounds 
12 compounds from Instituto Superior Técnico were screened by stopped-flow in this 
work: 3 of vanadium (P90, P91 and P103), 3 of copper (P93, P94 and P98), 3 of zinc (P96, P99 
and P102) and the 3 scaffolds (Phen, Amphen and Me2phen). The structures of these 12 
metallodrugs are compiled in the next image (Figure 3.1). 
Figure 3.1: Structures of the metallodrugs provided by the Instituto Superior Técnico. 
The metallodrugs arrived in powder to be prepared as a stock solution with DMSO. Most 
of them were prepared for a final concentration of 10 mM except for P103 and P102 which final 
concentration was 2.1 mM and 8.12 mM, respectively. NaVO3 and NH4VO3 were also prepared 
for a final concentration of 10 mM adjusting the pH solution at 10. Subsequently, all the 
compounds were diluted to 1 mM with phosphate buffer saline (PBS) solution to perform the 
permeability assays.   
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3.1.3. Gold compounds 
The gold compounds: RBA31, STAM013 and RBA29 from Cardiff University were 
screened in this work by stopped-flow. Their structures are summarized in the following image 
(Figure 3.2). 
Figure 3.2: Structures of the gold compounds provided by Cardiff University. 
 
These gold compounds arrived in powder to be prepared at a final concentration of 10 
mM. First, according to the instructions from Cardiff University, the compounds RBA31 and 
STAM013 were solubilized in water and RBA29 was solubilized in 50:50 (DMSO/water). After 
following this protocol, the compounds solubilization was not achieved even after cycles of 
sonication and heating. In a second try, RBA31 and STAM013 were solubilized in 50:50 
(DMSO/water) for a final concentration of 5 mM and then sonicated (two cycles of 15 minutes 
for RBA31 and one cycle of 15 minutes for STAM013). Then, they were diluted to a concentration 
of 1 mM to perform the experiments. RBA29 was dissolved to a final concentration of 5 mM in 
DMSO, being the working solution for the stopped-flow assays. 
3.2. RBCs assays 
The effect of the compounds on AQPs activity was first assessed in RBCs since these 
cells endogenously express a large amount of two aquaporin isoforms: AQP1, an orthodox 
aquaporin strictly selective to water and AQP3, an aquaglyceroporin that transports glycerol 
besides water [96]. These two isoforms are representative of the two major classes of aquaporins, 
rendering RBCs an excellent screening model to evaluate the inhibitory effect of compounds. 
3.2.1. Ethics statement 
Venous blood samples were obtained from healthy human volunteers following a 
protocol approved by the Ethics Committee of the Faculty of Pharmacy of the University of 
Lisbon. Informed written consent was obtained from all participants [92], [96]. 
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3.2.2. Buffers and solutions preparation 
The composition of the buffer used in RBCs assays is summarized in the following table. 
 Table 3.2: Composition of the phosphate buffered saline solution. 
 
 
 
 
The hyperosmotic solutions used to impose osmotic shocks and cell volume changes 
during the permeability assays, were based in PBS buffer solution adding sucrose (impermeant 
solute, inducing water movements) or glycerol (permeated through aquaglyceroporins, if these 
are functional). Osmotic solutions were prepared to a final concentration of 200 mM. 
3.2.3. Erythrocyte sampling, preparation and compound incubation 
First, venous blood samples were collected from an anonymous human donor in citrate 
anticoagulant (2.7% citric acid, 4.5% trisodium citrate and 2% glucose) to prevent coagulation. 
The blood was centrifuged at 750 × g for less than 10 minutes at room temperature (RT) to isolate 
the erythrocytes discarding the plasma (yellowish supernatant) and the white blood cells (white 
buffy coat). The RBCs isolated were washed with PBS, capped and inverted a few times to gently 
mix, being then centrifuged in the same conditions as previously mentioned. This wash was 
repeated two more times. Subsequently, the erythrocytes were diluted to a 0.5% suspension in 
which 250 µL of RBCs were added to 50 mL of PBS and kept on ice to be immediately used in 
the experiments. Each one of the compounds were incubated in 2 mL of 0.5% suspension for 30 
minutes at RT to assess their effect on RBCs permeability by stopped-flow experiments [96]. 
3.2.4. Reversibility assay 
To assess the reversibility of the inhibition on erythrocytes permeability by the most 
promising compounds tested, it was selected a fixed concentration higher than the IC50 value of 
the compound to be then incubated for 30 minutes at RT in 2 mL of RBCs suspension. 
Subsequently, they were washed with PBS or with the reducing agent 2-mercaptoethanol (Sigma-
Aldrich) prepared in 300 mM PBS. 
PBS buffer solution 300 mM pH 7.4 
Component Final concentration (mM) 
NaCl 137 
KCl 2.7 
Na2HPO4 10 
KH2PO4 1.8 
Adjust pH at 7.4 with HCl if necessary 
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In the first case, the erythrocytes with the compound were centrifuged at 750 × g for less 
than 10 minutes at RT and the supernatant was discarded. They were then washed with PBS, 
capped and inverted a few times to gently mix and the cells were centrifuged again. This wash 
was repeated one more time and with the final supernatant discarded, the RBCs were immediately 
tested by the stopped-flow technique.  
In the second case, 2 µL of 1 mM of 2-mercaptoethanol prepared in PBS was incubated 
in RBCs in the presence of the compound for 30 minutes at RT and were subsequently tested in 
the stopped-flow equipment. A sample of erythrocytes without compound was also incubated 
with this reducing agent to be used as a control of its effect. This assay allows to understand if the 
compound of interest binds to aquaporins’ cysteine residues since this reducing agent can compete 
for the same binding site [92]. 
3.3. Yeast assays 
3.3.1. Strains 
For the yeast assays, Saccharomyces cerevisiae strain -YSH 1770 – transformed with a 
recombinant plasmid – pUG35 - that grants the advantage of expressing only one aquaporin at a 
time, is available in our lab. YSH 1770 was silenced for endogenous aquaporins and subsequently 
transformed with recombinant plasmids constructed from amplified gene sequences that express 
the human aquaporins. Throughout this work, yeast cells were transformed with the empty vector 
and with plasmid encoding the following human aquaporins: 
• YSH 1770/pUG35 (empty vector); 
• YSH 1770/hAQP3; 
• YSH 1770/hAQP5 and mutants (H173A, H173W, S156A, S156E, S183A, S183E) with 
or without GFP; 
• YSH 1770/hAQP7; 
• YSH 1770/hAQP9; 
The plasmid pUG35 (from U. Güldener and J. H. Hegemann) was chosen since it allows 
the cloning of any gene of interest in line with yeast-enhanced green fluorescent protein (yEGFP3) 
gene, used as a reporter of Saccharomyces cerevisiae gene expression. Thus, when the expressed 
aquaporin is fused with GFP, it enables the detection of its localization in the cell. pUG35 has one 
selectable marker for Saccharomyces cerevisiae – URA3 – allowing the transformation of YSH 
1770 (auxotrophic for uracil) with this plasmid. Moreover, this gene region is under the regulation 
of MET25 promoter and when in presence of methionine, the aquaporins expression levels are 
significantly decreased. 
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Figure 3.3: Circular map of pUG35 vector with restriction site to insert the aquaporin gene, regulated by 
MET25 promoter and in line with yEGFP3, the GFP gene. 
Since these strains can express one aquaporin at a time allowing the validation of the 
potency and selectivity of the most promising aquaporin inhibitors, this model was used to 
validate the results obtained by RBCs assays. 
3.3.2. Buffers, culture media and amino acids preparation 
The composition of the buffer used to prepare the hyperosmotic and isotonic solutions for 
yeast assays is summarized in the following table. 
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 Table 3.3: Composition of the potassium-citrate buffer. 
 
 
 
The hyperosmotic solutions used to impose osmotic shocks and cell volume changes 
during the permeability assays, were based in potassium-citrate buffer solution adding sorbitol 
(impermeant solute, inducing water movements) or glycerol (permeated through 
aquaglyceroporins, if these are functional). Osmotic solutions were prepared to a final 
concentration of 2.1 M. The isotonic solution sorbitol at 1.4 M was also prepared in this buffer. 
              
             The composition of the culture media used to yeast growth is described in the following 
table. 
 
Table 3.4: Composition of the yeast nitrogen base (YNB) culture media for Saccharomyces cerevisiae. 
 
  
 
 
 
 
 
 
 
 
 
For the preparation of this culture media, YNB without amino acids was supplemented 
with the amino acids’ solutions prepared: histidine, leucine, tryptophan and methionine. After the 
culture media and amino acids solutions preparation, both must be sterilized via sterile vacuum 
filtration before usage. 
3.3.3. Growth and maintenance conditions 
 For the growth and maintenance of Saccharomyces cerevisiae -YSH 1770, the yeast cells 
were kept in test tubes in which the YNB culture media (supplemented with 2% (w/v) glucose, 
Potassium-citrate buffer (50 mM) pH 5.0 and pH 7.4 
Component Final concentration (mM) 
Potassium Citrate 50 
Phosphoric Acid 50 
This buffer is at pH 5.0. To have this buffer at pH 7.4, adjust the pH with KOH 
Component Final concentration 
Yeast Nitrogen Base without amino 
acids [10x] 
67 mg/mL 
Glucose [10x] 2% (w/v) 
Histidine 20 mg/mL 
Leucine 40 mg/mL 
Tryptophan 15 mg/mL 
Methionine 20 mg/mL 
Agar 2% (w/v) 
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2% (w/v) agar, 20 mg/mL histidine, 40 mg/mL leucine, 15 mg/mL tryptophan and 20 mg/mL 
methionine), was set at a slope and then grown at 27ºC for 48 hours.  
To perform the stopped-flow experiments, it was essential to do a pre-inoculum and an 
inoculum of the yeast cells and follow the culture growth by measuring the optical density (OD) 
at 600 nm in a spectrophotometer (Thermo Scientific Genesys 20). The pre-inoculum was done 
by cell growth at 27ºC overnight with constant stirring in YNB media supplemented with 2% 
(w/v) glucose, 20 mg/mL histidine, 40 mg/mL leucine, 15 mg/mL tryptophan and 20mg/mL 
methionine, being the latter the vector repressor, allowing the yeast growth without aquaporin 
expression. In the day after, methionine was removed from the culture by centrifugation at 5000 
× g for 10 minutes at RT, enabling the aquaporin expression and then yeast cells were inoculated 
in YNB media and grown at 27ºC overnight with constant stirring. In the next day, the cells were 
washed following a specific protocol and were ready to be used in the stopped-flow experiments. 
3.3.4. Storage of the yeast cells 
For the long-time storage of the yeast cells, they were kept in glycerol stocks at -80ºC. 
For this purpose, yeast cell cultures were inoculated in YNB media (2% (w/v) glucose, 20 mg/mL 
histidine, 40 mg/mL leucine, 15 mg/mL tryptophan and 20 mg/mL methionine) and they were 
grown overnight at 27ºC with constant stirring. In the following day, it was added 500 µL of pre-
sterilized 30% glycerol solution to 500 µL of cell culture for 5 replicates in microtubes, that were 
inverted before being stored at -80ºC. When needed, the strain was revived by scraping some cells 
off the cell stock partially thaw and then inoculated in YNB media solid plates (2% (w/v) agar, 
2% (w/v) glucose, 20 mg/mL histidine, 40 mg/mL leucine, 15 mg/mL tryptophan and 20 mg/mL 
methionine). 
3.3.5. Yeast cells preparation and compound incubation 
After the pre-inoculation, yeast cells were inoculated in YNB media (2% (w/v) glucose, 
20 mg/mL histidine, 40 mg/mL leucine and 15 mg/mL tryptophan) overnight at 27ºC in the 
absence of methionine. In the next day, the cells were harvested in the exponential phase (OD600nm 
≈ 1) by centrifugation at 5000 × g for 10 minutes at 4ºC. Then, the cell pellet was washed three 
times with sorbitol 1.4 M at pH 5.0 or pH 7.4 that is an isotonic solution prepared in 50 mM 
citrate-phosphate buffer to maintain cell balance and avoid pH interference throughout the 
experiments. After this set of centrifugations, the cell pellet was resuspended in 3 mL of the same 
isotonic solution per gram of pellet, to normalize the number of cells. To perform the stopped-
flow experiments, the yeast cells were preloaded for 20 minutes at 30ºC with the membrane-
permeable non-fluorescent precursor 5(6)-carboxyfluorescein diacetate (CFDA, Sigma-Aldrich) 
with a 1 mM concentration, that is cleaved intracellularly by nonspecific esterases, producing the 
impermeable fluorescent form, carboxyfluorescein. Since it is a volume sensitive fluorescent dye, 
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allows the observation of cell volume alterations inside the cell even though yeast cells possess a 
rigid cell wall. After the incubation with CFDA, the cells were diluted in sorbitol 1.4 M (1:10) to 
be immediately used in the experiments. Each one of the compounds were incubated in 2 mL of 
the cell suspension for 30 minutes at RT to assess their effect on yeast permeability by stopped-
flow experiments [102], [103].  
3.3.6. Detection of aquaporin localization through fluorescence microscopy 
For subcellular localization of GFP-tagged hAQP5 in Saccharomyces cerevisiae, yeast 
cells were first inoculated in YNB media (2% (w/v) glucose, 20 mg/mL histidine, 40 mg/mL 
leucine and 15 mg/mL tryptophan) overnight at 27ºC. When the cells were in the exponential 
phase, an aliquot of cell suspension was placed on a coverslip and were observed using a 
fluorescence microscope (Zeiss AAxiovert 200) at 495 nm excitation and 535 nm emission 
wavelengths. The images from the microscope were captured with a digital camera (CoolSNAP 
EZ, Photometrics, Tucson, AZ) using Metafluor software (Molecular Devices, Sunyvale, CA) 
[103].  
 
3.4. Aquaporins functional assays using the stopped-flow spectroscopy 
The stopped-flow technique is the main method used to determine the permeability of cell 
suspensions as RBCs and yeast cells [96] by following the fast-kinetics of cell volume changes 
over time in a millisecond-to-second scale after a rapidly imposed osmotic or solute gradient. 
These cell volume changes produce an analytical signal that is perceived by a suitable detection 
system with the ability of measuring scattering light intensity or fluorescence of a cell suspension 
[104]–[106]. An illustrative scheme of the apparatus operation is shown in Figure 3.4. 
 
 
 
 
 
 
30 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.4: Scheme of the stopped-flow technique . (Adapted from [104]). 
This approach uses two propelling syringes: one with cell suspensions balanced in an 
isotonic buffer and one with a solution with different osmolarity (hypo- or hyperosmotic solution) 
that, by a pneumatic device, inject equal volumes of the two solutions to a chamber where they 
are rapidly mixed, exposing the cells to an osmotic or solute gradient [106]. These solute or water 
fluxes from the inside and outside of the cell produce changes in the cell volume that leads to 
alterations in scattering light intensity in the case of RBCs or in fluorescence in the case of yeast 
cells [2]. The latter ones must be loaded with a volume sensitive fluorescent dye (such as CFDA). 
The data acquisition of the alterations in scattered light intensity or fluorescence starts when the 
flow suddenly stops by using a third stopping syringe, right after the mix of the two solutions 
where the cell suspension is subjugated to an osmotic shock [106]. Considering that there is a 
linear relation between the scattering light intensity or fluorescence measured and the cell volume, 
the water movements could be followed until osmotic equilibrium was reached. Then, by 
analysing the relative volume changes, it is possible to determine the osmotic (Pf) and solute 
permeability coefficients (Ps) [2]. 
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Throughout this work, the stopped-flow experiments were performed on a HI-TECH 
Scientific PQ/SF-53 apparatus, which has a 2 ms dead time (interval between the start of the 
mixing and the earliest possible observation time), temperature controlled and interfaced with a 
computer [105]. For both cell models, the experiments were performed at 23ºC for glycerol 
permeability (Pgly) and water permeability (Pf) and for each compound concentration, 4-10 
replicates were analysed. For the yeast cells, the Ea measurements were done in a temperature 
range between 9ºC and 34ºC.  
3.4.1. Functional assays for RBCs 
The RBCs functional assays were performed to assess the water and glycerol transport 
through AQP1 and AQP3 respectively, in control RBCs (absence of compound) and in the 
presence of an aquaporin inhibitor, at pH 7.4 (human physiological pH). To evaluate the water 
transport, 100 µL of a fresh erythrocytes’ suspension (0.5% suspension prepared in 300 mM PBS) 
was mixed with 100 µL of 200 mM hyperosmotic sucrose solution (500 mOsM) which is a non-
permeable solute that causes an osmotic gradient, leading to fast water efflux and consequently, 
to a rapid cell shrinkage [107] (Figure 3.5). 
 
 
Figure 3.5: Cell shrinkage due to water efflux after an imposed hyperosmotic gradient with a non-
permeable solute. (Adapted from [2]). 
 
To assess the effect of the compounds of interest, 2 mL of RBCs were incubated with 
different concentrations of compounds for 30 minutes at RT before the stopped-flow experiments. 
The time course of cell volume changes (5 seconds to observe water transport and 40 seconds to 
observe glycerol transport) was followed through alterations in scattered light intensity at 90º at 
the wavelength of 400 nm until a stable scatter signal was reached. When cells shrink, the scatter 
light increases and when they reswell, the scatter light decreases, demonstrating the linear relation 
between these two variables [108]. Then, Pf in control and treated RBCs was calculated by the 
following equation: 
Pf = k (V0/A)(1/Vw(osmout)∞)  (cm/s) 
where Vw is the molar volume of water, V0/A is the initial cell volume to area ratio, (osmout)∞ is 
the final medium osmolarity after the applied osmotic gradient and k is the single exponential 
time constant fitted to the light scattering signal of water efflux. The k (s-1) was determined by an 
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exponential fit to the acquired signal and was used to calculate the water permeability. Regarding 
the evaluation of the glycerol transport by AQP3, 100 µL of a fresh erythrocytes’ suspension 
(0.5% suspension prepared in 300 mM PBS) was mixed with 100 µL of 200 mM hyperosmotic 
glycerol solution (500 mOsM) which is a permeable solute that creates a glycerol gradient 
directed into the cell. The cells start to shrink due to water efflux while glycerol enters the cell as 
a result of its chemical gradient, leading also to water influx, and consequently, to cell reswelling. 
Since this solute is not diffused through the lipid bilayer, cell reswelling indicates glycerol influx 
via functional aquaporins (Figure 3.6). 
 
 
 
 
 
 
 
Figure 3.6: Cell volume change after imposing a hyperosmotic glycerol solution. First, the cells shrink 
rapidly due to water efflux while glycerol enters the cell followed by water influx, causing the reswelling 
of the cell. (Adapted from [2]). 
 
To assess the effect of the compounds in glycerol permeability, cells were treated with 
compounds at the same conditions previously described for water permeability. The Pgly in control 
and treated RBCs was determined by the following equation: 
Pgly = k (V0/A)  (cm/s) 
where k is the single exponential time constant fitted to the light scattering signal of glycerol 
influx. Just as performed for water permeability, k was determined by an exponential fit to the 
acquired signal for glycerol transport and was used to calculate the glycerol permeability.  
For the analysis of the compounds’ effect on AQP1 and AQP3 activity, the inhibitor 
concentration that corresponds to 50% inhibition – IC50 – was calculated by nonlinear regression 
of dose-response curves (GraphPad Prism software) using the following equation: 
y = 100/(1+10^((LogIC50-X) × HillSlope)) 
where HillSlope describes the steepness of the family of curves. 
 
3.4.2. Functional assays for yeast cells 
 
 Yeast cells were used to perform functional assays and assess the water transport through 
orthodox aquaporins (hAQP5 and respective mutants) and the glycerol transport through 
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aquaglyceroporins (hAQP3, hAQP7 and hAQP9) at pH 5.0 or pH 7.4, considering that pH 5.0 is 
the physiological pH for yeast cells growth and pH 7.4 is the physiological pH for human cells. 
Yeasts transformed with the empty vector were used as a control. To monitor the cell volume 
changes, the cells were loaded with CFDA, that is a concentration-dependent self-quenching 
fluorophore. CFDA is cleaved intracellularly by non- specific esterases yielding the impermeable 
fluorescent form that gets trapped inside the cells. When the cells shrink, the fluorophore 
concentration increases [109]. Therefore, when the cells are mixed with a hyperosmotic solution 
that causes water efflux, cells shrinkage can be followed by an increase in fluorescence. To 
evaluate water transport, 100 µL of cell suspension (1:10 dilution) in 1.4 M sorbitol was mixed 
with 100 µL of 2.1 M sorbitol, which is a hyperosmotic solution with a non-permeable solute that 
causes an osmotic gradient leading to fast water efflux and consequently, to cell shrinkage. The 
two solutions of sorbitol (1.4 M and 2.1 M) were prepared in potassium-citrate buffer at pH 7.4 
or pH 5.0. To assess the effect of the compounds of interest, 2 mL of yeast cells suspension were 
incubated with different concentrations of compound for 30 minutes at RT before the stopped-
flow experiments. The fluorophore was excited using the light source with a 470 nm interference 
filter and detected using a 530 nm cut-off filter. The time course of cell volume change (5 - 10 
seconds for water transport and 50 seconds for glycerol transport) was followed by fluorescence 
quenching of the intracellular fluorophore [110]. To evaluate the glycerol transport, 100 µL of 
cell suspension (1:10 dilution) in 1.4 M sorbitol was mixed with 100 µL of 2.1 M glycerol, which 
is a hyperosmotic solution (2.1 OsM) with a permeable solute that causes a glycerol gradient 
driven into the cell [103]. The cells start to shrink due to water efflux while glycerol enters the 
cell as a result of its chemical gradient, leading also to water influx, and consequently, to cell 
reswelling. Since this solute is not diffused through the lipid bilayer, cell reswelling indicates 
glycerol influx via functional aquaporins. The solutions of 1.4 M of sorbitol and 2.1 M of glycerol 
were prepared in potassium-citrate buffer at pH 7.4. To assess the effect of the compounds of 
interest, cells were incubated with compounds at the same conditions described above for water 
permeability. In a first stage, Pgly and Pf were determined by the same equations used to calculate 
the water and glycerol permeabilities for RBCs assays. The analysis of the compound’s effect in 
the aquaporins was evaluated by IC50 values determined by nonlinear regression of dose-response 
curves using GraphPad Prism, as performed for RBCs assays.  
To obtain accurate permeability values in yeast cells experiments, in situations where the 
fluorescent signal produced by yeast cell volume change turned out difficult to analyse, the 
software Berkeley Madonna was used to obtain Pf and Pgly using customized mathematical models 
previously published by our group [103], [111].  To use this tool, the output fluorescence signal 
was converted into relative cell volume (Vrel) for both water and glycerol transport. The converted 
traces obtained enable to directly relate the cell volume change along the time, allowing to directly 
visualize the cell behaviour in response to an osmotic shock. This transformation was achieved 
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by: (V/V0) = Vrel = a F + b where V is the cell volume attained after an osmotic shock, V0 is the 
initial cell volume being the ratio of V/ V0 the relative change in cell volume, F is the ratio F/F0 
that represents the variation of the fluorescence signals and a (slope) and b (y-intercept) are 
constants that were estimated for each osmotic perturbation using the Berkeley Madonna 
software. This software uses mathematical models that allow the simulation of the cell volume 
behaviour when subjugated to osmotic or solute gradients and enable the estimation of 
permeability parameters by fitting theoretical curves to the experimental data of cell volume 
changes [103], [111]. To obtain these permeability values, it was first necessary to provide to the 
model some data such as the universal gas constant (R), the absolute temperature (T), the molar 
volume of water (Vw), the initial fluorescence value (F0), the start and stop time, the initial cell 
radius (r), the tonicity (ʌ), the initial external osmolarity ((osmout)0), the added osmolarity and also 
the initial values estimated for Pf and Pgly. Therefore, by running the model with all the equations 
needed, it was possible to determine and optimize the values of water and glycerol permeability. 
Furthermore, the activation energies (Ea) for water transport were assessed by performing the 
permeability assays at a range of temperatures from 9ºC to 34ºC, and were determined from the 
slope of the Arrhenius plot that relates the ln of the permeabilities with the inverse of the 
temperature (1/T): ln(P) = ln(A) - 
−Ea 
R
1
T
 where P is the water or glycerol permeability (cm/s), A 
is the pre-exponential factor, Ea is the activation energy (kcal.mol
-1), R is the universal gas 
constant (J.K−1.mol−1) and T is the absolute temperature (K) [6].  To calculate Ea, Pf was 
determined at various temperatures since at high temperatures, diffusion through the lipid 
membrane dominates and at low temperatures, where lipids are more rigid, water transport 
through aquaporin channels is dominant [5]. Considering these two pathways for water 
permeability, lower activation energies indicate that water is being transported through aquaporin 
channels and higher Ea indicates that water crosses the membrane via the hydrophobic bilayer. 
 
3.5. Statistical analysis 
Data are presented as mean ± standard error of the mean (SEM).  Data were first analysed 
with Shapiro-Wilk normality test to understand if the data followed a Gaussian distribution and 
then analysed using the student’s t-test. For the first test, a value of P ≤ 0.05 meant that the 
assumption of a normal distribution had to be rejected and for the second test, a value of P < 0.05 
meant that the data were statistically significant. 
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4. Results and Discussion 
4.1. Screening of metallodrugs as aquaporin inhibitors 
It is known that RBCs largely express AQP1, that is strictly selective to water and AQP3, 
that transports glycerol and other small solutes besides water. This indicates that RBCs are a good 
screening model to unveil new potent and selective aquaporin inhibitors since they can be tested 
in AQP1, an orthodox aquaporin and in AQP3, an aquaglyceroporin, enabling the direct 
evaluation of their effect in water and glycerol permeability, respectively, by the stopped-flow 
technique.  To assess the effect of the compounds in water and glycerol permeability, 2 mL of 
RBCs were incubated with different metallodrugs at different concentrations for 30 minutes at 
RT. Afterwards, using the stopped-flow technique, RBCs were rapidly mixed with 200 mM 
hyperosmotic sucrose solution to evaluate the water permeability or with 200 mM hyperosmotic 
glycerol solution to evaluate the glycerol permeability. These two hyperosmotic solutions impose 
osmotic shocks, changing the cell volume and consequently, altering the scattered light intensity. 
The representative stopped-flow traces of water and glycerol transport in control RBCs and in the 
presence of aquaporin inhibitors are shown in the following figure. (Figure 4.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Traces of water and glycerol transport through cell membrane. A – Stopped-flow representative 
signal for water transport after imposing a hyperosmotic sucrose solution to the cells, in control RBCs and 
in the presence of inhibitor. B – Stopped-flow representative signal for glycerol transport after imposing a 
hyperosmotic glycerol solution to the cells, in control RBCs and in the presence of an inhibitor. 
 
By Figure 4.1A, it is observed that after an imposed hyperosmotic sucrose solution, the 
volume of the control cells starts to decrease showing that the sucrose solution, as a non-
permeable solute, creates an osmotic gradient that leads to the fast water efflux and consequently, 
to a rapid cell shrinkage. In the presence of an inhibitor, the water takes longer to exit the cell 
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considering that the aquaporin is blocked and cannot facilitate the water transport, thus the water 
only passes through the membrane lipids. Under the conditions of a hyperosmotic glycerol 
solution, which is a permeable solute, the control erythrocytes start to shrink due to the water 
outflow while glycerol starts to enter the cell as a response to its chemical gradient, leading also 
to water influx and consequently, to cell reswelling. In the presence of an inhibitor, there is no 
glycerol uptake since the glycerol transport is blocked. Thus, the cells shrink and are not capable 
to reswell. The stopped-flow experiments were performed at 23ºC for pH 7.4 (human 
physiological pH) and for each tested concentration, 4 signals were acquired. From doing an 
exponential fit to these signals, it was possible to determine the k (s-1) and consequently, to 
calculate the Pf and Pgly for the control cells and the for the presence of the metallodrugs. 
In order to validate the results obtained by the RBCs assays, the most promising 
metallodrugs were tested in yeast cells. In Saccharomyces cerevisiae -YSH 1770, the genes 
expressing endogenous aquaporins were silenced (aqy-null cells) being then transformed with 
pUG35 plasmid to grant the advantage of expressing only one human aquaporin at a time. 
For this purpose, cells incubated with the volume sensitive dye CFDA, balanced in an 
isotonic solution, were treated with the metallodrugs at different concentrations for 30 minutes at 
RT and were then mixed with a 2.1 M hyperosmotic glycerol solution to evaluate glycerol 
permeability, using the stopped-flow fluorescence. All the experiments were performed at 23ºC 
for pH 7.4, since mammalian aquaporins are being expressed, and 5 signals were acquired for 
each concentration. It was possible to calculate Pgly by determining the k through an exponential 
fit of the acquired signals in the absence and in the presence of compound. To obtain accurate 
permeability values in yeast cells experiments, in situations where the fluorescent signal produced 
by yeast cell volume change turned out difficult to analyse, the software Berkeley Madonna was 
used to obtain Pf and Pgly using customized mathematical models previously published by our 
group [103], [111]. Through this software, the fluorescence signals were converted to relative cell 
volume to obtain traces that enable the direct visualization of the cell behaviour in response to an 
osmotic shock, as for the signals in RBCs assays.  
For both RBCs and yeast assays, for the study of the metallodrugs’ inhibitory effect on 
glycerol transport, it was necessary to calculate the IC50 (mean ± SEM) by doing a nonlinear 
regression of the dose-response curves for each of them, using GraphPad Prism. 
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4.1.1. Inhibition studies of water and glycerol permeability in aquaporins by 
polyoxometalates 
4.1.1.1. Inhibitory effect of polyoxometalates in RBCs permeability 
 
The 11 polyoxometalates compounds were grouped in three sets and labelled: 1 and 3 are 
polyoxotungstates, 4 to 7 are polyoxovanadates, and A, B, C, E and F are polyoxotungstates. They 
were first screened in RBCs in the conditions mentioned above and in the following figure, it is 
possible to observe the effect induced by polyoxometalates on AQP1 (water permeability) and on 
AQP3 (glycerol permeability), expressed as the percent of permeability relative to the control (%) 
(Figure 4.2). 
Figure 4.2: Inhibition of water and glycerol transport in RBCs by eleven polyxoxometalates at a 
concentration of 100 µM after 30 minutes incubation at RT. Data are shown as media ± SEM for one or 
two experiments. Significance levels: **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05, ns – 
nonsignificant, compared to the control by student t-test. 
By Figure 4.2, it was possible to observe that most of the compounds exhibited glycerol 
permeability inhibition except for compounds 4, 5, 6 and 7. Considering that these four 
compounds are the only ones that contain vanadium as a bonding metal to AQP3, this suggests 
that polyoxovanadates (POVs) have no effect on glycerol permeability and therefore, they are not 
AQP3 inhibitors.  Even though the values of glycerol permeability for POV-6 showed to be 
statistically significant relative to the control probably due to its low SEM, POV-6 inhibition has 
a weak inhibition potency on AQP3 which is confirmed by the very close values of Pgly for control 
cells and for the presence of POV-6: (1.30 ± 0.02) × 10-5 (cm/s) and (1.17 ± 0.02) × 10-5 (cm/s), 
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respectively. In addition, their lack of effect on water permeability also indicated that they did not 
show potential to be AQP1 inhibitors.  
The polyoxotungstates (POTs), in general, showed inhibition of glycerol permeability, 
revealing their potential as AQP3 inhibitors. Moreover, they presented a slight effect on water 
permeability except for POT-A that showed the higher inhibition of water transport of all these 
compounds. A plausible explanation is that AQP3 transports both water and glycerol and since 
POT-A inhibited drastically the glycerol transport of AQP3, suggested that the percent of 
inhibition of water permeability corresponded to the inhibition of AQP3 water transport. 
Furthermore, it was not possible to analyse the water and glycerol transport in the presence of 
POT-E as it did not solubilize, causing the erythrocytes’ hemolysis. Overall, polyoxotungstates 
did not exhibit potential to be AQP1 inhibitors, however their potential to be AQP3 inhibitors is 
a valuable starting point to discover a potent and selective inhibitor that could later be used for 
cancer therapeutics, which is the aim of this work. 
The following graphs display the results obtained for the inhibition of glycerol 
permeability by polyoxotungstates and IC50 values (Figure 4.3 to Figure 4.8). 
 
 
 
 
 
 
 
Figure 4.3: Inhibitory effect of POT-1 on RBCs glycerol permeability. A - Concentration dependent 
inhibition of glycerol permeability in RBCs by POT-1 for concentrations between 0.1-100 µM (incubated 
for 30 minutes at RT) with an IC50 value of (2.78 ± 0.09) µM (n=2) B – Stopped-flow signal for glycerol 
transport after imposing a hyperosmotic glycerol solution on the cells, for control RBCs and in the presence 
of 100 µM of POT-1. 
 The value determined for the IC50 of POT-1 was (2.78 ± 0.09) µM and by being a low 
concentration value (micromolar range), it demonstrated that this compound strongly inhibited 
the glycerol permeability. This inhibition can be observed in Figure 4.3B, where after the osmotic 
shock, the RBCs in the presence of this POT were not capable of reswelling since AQP3 was 
inhibited and could not facilitate the glycerol transport into the cell. Consequently, there was no 
water influx through this aquaporin, leading to cell shrinkage. Considering that Auphen is a 
A B 
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known AQP3 potent inhibitor with an IC50 of (0.8 ± 0.08) µM, it suggested that POT-1 was not 
as potent as Auphen since the IC50 value for POT-1 was higher. 
 
Figure 4.4: Inhibitory effect of POT-3 on RBCs glycerol permeability. A - Concentration dependent 
inhibition of glycerol permeability in RBCs by POT-3 for concentrations between 0.1-100 µM (incubated 
for 30 minutes at RT) with an IC50 > 50 µM (n=1) B – Stopped-flow signal for glycerol transport after 
imposing a hyperosmotic glycerol solution on the cells, for control RBCs and in the presence of 100 µM of 
POT-3. 
 
 By Figure 4.4A, it was interpreted that POT-3 slightly inhibited the glycerol permeability 
with an IC50 higher than 50 µM. Accordingly, as observed in Figure 4.4B, the cells could still 
reswell in its presence which confirmed that this compound is not a potent AQP3 inhibitor.  
Figure 4.5: Inhibitory effect of POT-A on RBCs glycerol permeability. A - Concentration dependent 
inhibition of glycerol permeability in RBCs by POT-A for concentrations between 0.1-100 µM (incubated 
for 30 minutes at RT) with an IC50 value of (0.71 ± 0.04) µM (n=2) B – Stopped-flow signal for glycerol 
transport after imposing a hyperosmotic glycerol solution on the cells, for control RBCs and in the presence 
of 100 µM of POT-A. 
B A 
A B 
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 POT-A exhibited a very low IC50 value of (0.71 ± 0.04) µM showing that this compound 
drastically inhibited the glycerol transport of AQP3. This evidence was supported by the cell 
behaviour showed in Figure 4.5B where the RBCs treated with this compound, after being 
exposed to a hyperosmotic glycerol solution, did not reswell as AQP3 was blocked and could not 
facilitate the glycerol transport into the cell. Therefore, the cells shrink due to the water efflux 
caused by the osmotic shock. Comparing to the potent inhibitor of AQP3 – Auphen – POT-A 
displayed a very similar IC50 value: 0.8 µM for Auphen and 0.71 µM for POT-A. This revealed 
that POT-A was as potent as Auphen in inhibiting AQP3 being this polyoxotungstate the most 
promising inhibitor of AQP3 glycerol permeability of all the POTs that were tested. Moreover, in 
the literature, this compound has exhibited high inhibitory activity for Na+/K+ ATPase (100% 
inhibition at 10 µM) and for Ca2+-ATPase (IC50 = 0.6 µM), showing a similar inhibitory effect 
both on P-type ATPases and on AQP3 [87]. 
Figure 4.6: Inhibitory effect of POT-B and POT-C on RBCs glycerol permeability. A - Concentration 
dependent inhibition of glycerol permeability in RBCs by POT-B for concentrations between 0.1-100 µM 
(incubated for 30 minutes at RT) with an IC50 > 50 µM (n=1) B – Concentration dependent inhibition of 
glycerol permeability in RBCs by POT-C for concentrations between 0.1-100 µM (incubated for 30 
minutes at RT) with an IC50 > 100 µM (n=1). 
 By Figure 4.6, it was observed that both POT-B and POT-C slightly inhibited the glycerol 
permeability since they presented high values of IC50. Therefore, these two POTs did not affect 
the AQP3 activity and had no potential to be AQP3 inhibitors. 
 
 
 
 
 
 
 
 
A B 
41 
 
 
 
 
 
 
Figure 4.7: Inhibitory effect of POT-F on RBCs glycerol permeability. A - Concentration dependent 
inhibition of glycerol permeability in RBCs by POT-F for concentrations between 0.1-100 µM (incubated 
for 30 minutes at RT) with an IC50 value of (3.10 ± 0.05) µM (n=2) B – Stopped-flow signal for glycerol 
transport after imposing a hyperosmotic glycerol solution on the cells, for control RBCs and in the presence 
of 100 µM of POT-F. 
By Figure 4.7A, it was noticeable that POT-F exhibited a low IC50 value of about (3.10 
± 0.05) µM, demonstrating its potency in decreasing the glycerol transport via inhibition of AQP3. 
In Figure 4.7B, it was shown that in the presence of this compound, the cells subjugated to an 
osmotic shock could not reswell since AQP3 is blocked. This cell behaviour suggested that AQP3 
was strongly inhibited and could not facilitate the glycerol transport into the cell. Comparing this 
POT to Auphen, that has an IC50 of 0.8 µM, it was possible to affirm that POT-F was not as potent 
in inhibiting the glycerol permeability via AQP3 as Auphen. The same could be concluded by 
comparing the IC50 from POT-F with the ones for POT-1 and POT-A, since both exhibited lower 
IC50 values than 3.10 µM. 
Overall, POT-A revealed to be the most promising AQP3 inhibitor of this set of 
compounds with a very low IC50 value (0.71 ± 0.04) µM. Hence, this compound exhibited great 
potency and efficacy in inhibiting glycerol transport in RBCs.  
In order to assess the reversibility of AQP3 inhibition by POT-A and understand the 
possible binding sites of this compound, it was selected a fixed concentration of 5 µM, higher 
than the IC50 value (0.71 µM), to be incubated in 2 mL of RBCs suspension for 30 minutes at RT. 
After the incubation period, cells were washed with PBS or with 1 mM of the reducing agent, 2-
mercaptoethanol prepared in 300 mM PBS. The results from this assay are shown in the next bar 
graph (Figure 4.8). 
A B 
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Figure 4.8: Inhibition of glycerol permeability of RBCs after treatment with 5 µM of POT-A (incubated 
for 30 minutes at RT) and assessment of reversibility by washing with PBS or by incubation with 1 mM 
of 2-mercaptoethanol (for 30 minutes at RT). Data are shown as media ± SEM for one experiment. 
Significance levels: *** P < 0.001, compared to the control by student t-test. 
As observed in Figure 4.8, washing the cells with PBS led to a partial recovery of glycerol 
permeability of about 50%, indicating that the bonding of POT-A to the aquaporin is partially 
reversible. Thus, AQP3 activity can still be partially recovered by washing with PBS, even after 
being incubated with the compound. Concerning the incubation with 1 mM of 2-mercaptoethanol, 
this assay is usually performed to understand if the compound binds AQP3 cysteine residues since 
this reducing agent can compete for the same binding site. This was investigated for Auphen that 
showed that its gold ions had affinity to bind to sulfhydryl groups, suggesting that 2-
mercaptoethanol competed with this compound, leading to an almost complete recovery of 
glycerol permeability via AQP3. By Figure 4.8, it is noticed that in the presence of this reducing 
agent, the glycerol permeability recovered poorly so it is very likely that POT-A has no binding 
affinity for AQP3’s cysteine residues. Accordingly, there was no competition with 2-
mercaptoethanol for sulfhydryl groups hence, further studies are needed to identify the binding 
sites to which tungstate shows affinity. 
 
4.1.1.2. Inhibitory effect of POT-A in aquaporin-expressing yeast cells 
permeability 
POT-A was tested in yeast transformed with either the empty plasmid pUG35 and in yeast 
transformed with plasmid encoding human AQP3 (hAQP3), hAQP7 or hAQP9, which were the 
aquaglyceroporin-expressing strains available in the lab at the time. The results obtained for the 
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effect induced by POT-A on glycerol permeability for the three aquaglyceroporins: hAQP3, 
hAQP7 and hAQP9 are shown in the next graphs (Figure 4.9). 
 
 
 
 
 
Figure 4.9: Inhibitory effect of POT-A in pUG35, hAQP3, hAQP7 and hAQP9. A - Effect of POT-A in 
pUG35, hAQP3, hAQP7 and hAQP9 (incubation for 30 minutes at RT at a concentration of 100 µM and 
50 µM for pUG35 cells). Data are shown as media ± SEM for one experiment. B – Time course of the 
relative cell volume changes after a hyperosmotic glycerol solution, for yeast cells transformed with 
plasmid encoding hAQP3 in the absence of compound and in the presence of 100 µM of POT-A. 
Significance levels: *** P < 0.001, * P < 0.05, ns – nonsignificant, compared to the control by student t-
test. 
From Figure 4.9A, it was observed that POT-A drastically inhibited glycerol 
permeability via AQP3 with a percent of inhibition near 100 %. This can also be confirmed 
considering that the values of glycerol permeability for hAQP3 in presence of POT-A and for 
empty vector control are very similar: (1.42 ± 0.20) × 10-7 (cm/s) and (1.21 ± 0.09) × 10-7 (cm/s), 
respectively, demonstrating that AQP3 is fully blocked by POT-A action. This AQP3 blockage is 
corroborated by Figure 4.9B, where the yeast cells expressing hAQP3 treated with POT-A, did 
not reswell after being subjugated to a hyperosmotic glycerol solution since AQP3 was drastically 
inhibited and could not facilitate the glycerol transport into the cell. 
For both hAQP7 and hAQP9, the glycerol permeability was not affected by this 
compound, thus POT-A does not show potential to be an AQP7 or AQP9 inhibitor. Overall, the 
stopped-flow experiments with aquaporin-expressing yeast cells validated the results from RBCs 
assays, since it was confirmed that POT-A is the most promising compound in inhibiting AQP3 
glycerol permeability of this set of polyoxometalates. Besides confirming that this compound is 
a potent inhibitor of AQP3, the data about the inhibitory effect of POT-A in three 
aquaglyceroporins allowed to conclude that POT-A is selective to AQP3, considering that it 
drastically inhibits AQP3 and has no effect on AQP7 and AQP9. Comparing with Auphen that 
inhibits both AQP3 and AQP7, POT-A exhibits great advantage in being potent and selective to 
AQP3. Further studies with POT-A are needed to establish structure/activity relationships and to 
confirm its potential as a suitable drug candidate by testing it in cancer cell lines (on-going studies 
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in our lab), in order to investigate its anticancer properties and possible applications in cancer 
therapy. 
4.1.2. Inhibition studies of water and glycerol permeability in aquaporins by 
vanadium, copper and zinc compounds 
4.1.2.1. Inhibitory effect of vanadium, copper and zinc compounds in 
RBCs permeability 
12 metallodrugs were screened in RBCs: 3 of vanadium (P90, P91 and P103), 3 of copper 
(P93, P94 and P98), 3 of zinc (P96, P94 and P98) and the 3 scaffolds (Phen, Amphen and 
Me2phen) which structures are represented in Figure 3.1 in Materials and Methods section. 
Moreover, NaVO3 and NH4VO3 were also tested to assess the effect of vanadium without the 
presence of scaffolds. The inhibitory effect of these metallodrugs on water permeability mediated 
by AQP1 and on glycerol permeability mediated by AQP3 is showed in the next bar graph, 
expressed as the percent of permeability relative to the control (%) (Figure 4.10). 
Figure 4.10: Inhibition of water and glycerol transport in RBCs by metallodrugs at a concentration of 100 
µM after 30 minutes incubation at RT. For P103, the maximum concentration tested was 20 µM considering 
that above this concentration, the cells decrease their volume due to the effect of the compound. Data are 
shown as media ± SEM from one to three experiments. Significance levels: **** P < 0.0001, *** P < 
0.001, * P < 0.05, ns – nonsignificant, compared to the control by student t-test. 
 
 Most of the compounds inhibited the glycerol and water permeability, except for 
compounds NaVO3 and NH4VO3 that showed permeability’s inhibitions with very low or none 
significance. This can be explained by the fact that these two compounds were composed of free 
vanadium and by neither of the three scaffolds that inhibited RBCs permeability, suggesting that 
vanadium in the absence of one of these scaffolds, was not capable of affecting neither glycerol 
nor water permeability. Therefore, NaVO3 and NH4VO3 do not have potential to be AQP1 or 
AQP3 inhibitors.  
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 In general, the majority of the set of metallodrugs and their scaffolds showed similar 
values of percent of inhibition for water and glycerol permeability, suggesting that their inhibitory 
effect is probably due to the presence of the scaffolds. To understand if these compounds had the 
potential to be AQP1 and AQP3 inhibitors, the IC50 value was calculated for each one.  
The following graphs display the results obtained for the inhibition of glycerol and water 
permeability by metallodrugs of vanadium, copper and zinc and their IC50 values (Figure 4.11 to 
Figure 4.14). 
Figure 4.11: Inhibitory effect of vanadium compounds (P90, P91 and P103) in RBCs permeability. A - 
Concentration dependent inhibition of water permeability in RBCs by P90 and P91 for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 > 50 µM (n=2 for P90 and n=3 for 
P91). B – Concentration dependent inhibition of water permeability in RBCs by P103 for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 value of (9.11 ± 0.03) µM (n=2). C - 
Concentration dependent inhibition of glycerol permeability in RBCs by P90 and P91 for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 > 50 µM (n=2 for P90 and n=1 for 
P91). D - Concentration dependent inhibition of glycerol permeability in RBCs by P103 for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 value of (21.17 ± 0.07) µM (n=1). 
 By Figures 4.11A and 4.11C, it was noticeable that both P90 and P91 slightly inhibited 
the glycerol and water transport by AQP3 and AQP1 respectively, considering their high IC50 
values. Therefore, these two vanadium compounds did not show potential to be inhibitors of 
glycerol and water permeability. Concerning P103, this metallodrug greatly inhibited the water 
permeability, exhibiting an IC50 value of (9.11 ± 0.03) µM. This result is very promising 
considering that until now, there is no known potent AQP1 inhibitors. Therefore, with an IC50 
value in the micromolar range, P103 has reveal its potential to be an AQP1 inhibitor. However, it 
A B 
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is important to highlight that at concentrations above 20 µM, the presence of the compound in the 
cells leads to a decrease in cell volume, so this compound should not be use above this 
concentration. For the determination of the IC50 value, the water permeability values for 
concentrations above 20 µM were included to get a better dose-response curve. Moreover, the 
inhibition of the water transport by P103 is also confirmed by the following graph (Figure 4.12). 
 
 
 
 
 
 
 
Figure 4.12: Stopped-flow signal for water transport after imposing a hyperosmotic sucrose solution on 
the cells, for control RBCs and in the presence of 20 µM of P103. 
 These stopped-flow traces support the high inhibition of water permeability by P103 since 
it represents the cell behaviour in the presence of this compound. After being exposed to a 
hyperosmotic sucrose solution, the cells shrink due to the water efflux caused by the osmotic 
shocks. Considering that AQP1 is inhibited and cannot facilitate the water transport, the water 
takes more time to exit the cell since it can only pass through the lipid bilayer. About the glycerol 
permeability, P103 presented a high IC50 value of (21.17 ± 0.07) µM, thus it weakly inhibited the 
glycerol transport. Therefore, it did not show potential to be an AQP3 inhibitor as Auphen or 
POT-A that presented much lower IC50 values.  
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Figure 4.13: Inhibitory effect of copper compounds (P93, P94 and P98) in RBCs permeability. A - 
Concentration dependent inhibition of water permeability in RBCs by copper compounds for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 > 50 µM (n=1 for all compounds). B – 
Concentration dependent inhibition of glycerol permeability in RBCs by copper compounds for 
concentrations between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 > 45 µM (n=1 for all 
compounds).  
 In Figure 4.13, it was observed that copper compounds weakly inhibited water and 
glycerol permeability, presenting high IC50 values above 45 µM. Therefore, these metallodrugs 
did not exhibit strong efficacy in inhibiting any of the two aquaporins expressed in RBCs. 
Furthermore, it is known by the literature that Cuphen inhibits the glycerol permeability with an 
IC50 value of (81.9 ± 4.1) µM which agrees with the results obtained for P93, P94 and P98, 
especially for P93 which scaffold corresponds to two molecules of Phen [92]. 
 
Figure 4.14: Inhibitory effect of zinc compounds (P96, P99 and P102) in RBCs permeability. A - 
Concentration dependent inhibition of water permeability in RBCs by zinc compounds for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 > 50 µM (n=1 for all compounds). B – 
Concentration dependent inhibition of glycerol permeability in RBCs by zinc compounds for concentrations 
between 0.1-100 µM (incubated for 30 minutes at RT) with an IC50 > 50 µM (n=1 for all compounds). 
B A 
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 The three zinc compounds slightly inhibited glycerol and water permeability, displaying 
high IC50 values above 50 µM. Thus, zinc did not exhibit high efficacy in inhibiting AQP1 and 
AQP3 and so, these metallodrugs are not potential inhibitors of water or glycerol transport. 
 For the scaffolds Phen, Amphen and Me2phen, the IC50 values were not determined. 
However, it seems that for most of the compounds, their inhibitory effect is due to the presence 
of the scaffolds, since they show similar values of percent of inhibition for water and glycerol 
permeability. By the literature, it is known that Phen does not inhibit the glycerol permeability 
which is not confirmed by the results obtained for the scaffolds with a 100 µM concentration. 
Considering this is a high concentration that could possibly disturb the membrane lipids instead 
of actually inhibit the aquaporins, these compounds were also tested at 10 µM to confirm the 
literature results for Phen (that was tested at 10 µM concentration in the literature) and to ensure 
that the observed decrease in permeability is due to the inhibitory effect of the compounds [96]. 
The results from testing the compounds at 10 µM are shown in the next bar graph (Figure 4.15) 
 
Figure 4.15: Inhibition of water and glycerol transport in RBCs by metallodrugs at a concentration of 10 
µM after 30 minutes incubation at RT. Data are shown as media ± SEM from one to three experiments. 
Significance levels: **** P < 0.0001, *** P < 0.001, ** P < 0.01, * P < 0.05, ns – nonsignificant, compared 
to the control by student t-test. 
 From Figure 4.15, it can be observed that most of the compounds and their scaffolds, 
presented similar values of percent of inhibition of both water and glycerol permeability, as 
observed for 100 µM. This corroborates the hypothesis that the inhibitory effect of most 
compounds was due to being composed by one of the three scaffolds under study. However, at 
this concentration, the water and glycerol permeability inhibition were very weak for nearly all 
the metallodrugs tested with a maximum inhibition of approximately 15%, which also 
corroborates the results from the literature about the non-inhibitory effect of Phen in glycerol 
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permeability. Moreover, the only compound exhibiting a strong inhibition of water transport was 
P103, being the most promising compound in inhibiting AQP1. This suggest that the effect of the 
compound on AQP1 was not only due to the effect of the scaffold but also to the effect of the 
vanadium metal, since P103 showed a higher percent of inhibition than the scaffolds, with a 
difference of almost 50% between them. Furthermore, P103 slightly inhibits the glycerol 
permeability showing a high SEM, suggesting that more studies are needed to draw conclusions 
about P103 selectivity towards AQP1. 
Overall, P103 revealed to be the most promising AQP1 inhibitor of this set of compounds, 
with an IC50 value of (9.11 ± 0.03) µM. Hence, this compound exhibited great potency and 
efficacy to AQP1 inhibition, suggesting that both the vanadium metal and the two molecules of 
Amphen contributed to the water transport inhibition. Further studies are needed to validate these 
results by testing P103 in yeast cells transformed with plasmid encoding AQP1 and yeast cells 
transformed with plasmid encoding AQP3. In addition, it is also necessary to study its 
reversibility, establish structure/activity relationships and then, test it in cancer cell lines (on-
going work), to understand if P103 is a suitable AQP1 inhibitor that could be used in cancer 
therapy. 
4.1.3. Inhibition studies of water and glycerol permeability in aquaporins by 
gold compounds 
4.1.3.1. Inhibitory effect of gold compounds in RBCs permeability 
 Three gold compounds from Cardiff University were screened in RBCs: RBA31, 
STAM013 and RBA29. The interest in investigating new gold compounds as potential AQP3 
inhibitors started when it was discovered a potent and selective inhibitor of glycerol permeability 
– Auphen – that is a water-soluble gold (III) coordination compound [92], [96]. Remarkably, 
Auphen strongly inhibited glycerol permeability in RBCs, with an IC50 value of (0.80 ± 0.08) µM 
and exhibited a slight inhibition on water permeability mediated by AQP1. Considering these 
promising results, RBA31 and STAM013 were synthetized considering the Auphen structure to 
try to optimize its efficiency, potency and selectivity towards AQP3. On the other hand, RBA29 
was also synthetized based on the Auphen structure in order to obtain a compound capable of 
inhibiting AQP9, that is an aquaglyceroporin that as still no known potent inhibitors. Considering 
that AQP9 has a positively charged extracellular surface [112], this will attract anions and for that 
reason, RBA29 was synthetized to become an anion by deprotonation of the hydroxyl group from 
the carboxylic acid, capable of interacting with hAQP9 (Figure 4.16). 
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Figure 4.16: Protonated and deprotonated state of the gold compound RBA29 provided by Cardiff 
University 
The inhibitory effect of the gold compounds on water and glycerol permeability in RBCs 
is displayed in the following bar graph, expressed as the percent of permeability relative to the 
control (%) (Figure 4.17). 
Figure 4.17: Inhibition of water and glycerol permeability in RBCs by gold compounds at a concentration 
of 100 and 10 µM after 30 minutes incubation at RT. Data are shown as media ± SEM for one or three 
experiments. Significance levels: *** P < 0.001, ns – nonsignificant, compared to the control by student t-
test. 
 In Figure 4.17, besides the percent of inhibition for the maximum concentration tested 
(100 µM), it is also shown the inhibition observed for testing 10 µM of each compound to 
facilitate the comparison with Auphen that exhibits its maximum inhibition of glycerol 
permeability at 10 µM. At both concentrations, RBA29 exhibited a strong inhibition of glycerol 
permeability, while RBA31 and STAM013 at 100 µM decreased the glycerol permeability to 
35%, showing less potency than RBA29. At 10 µM, these two compounds were unable to inhibit 
the glycerol transport, suggesting that the structural differences from Auphen were determinant 
to cause the lack of potency of these compounds to AQP3. By analysing the structures, the 
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difference between the two compounds and Auphen is that the gold compound is bound to three 
nitrogen atoms from the scaffold and is not bound to two chloride atoms as Auphen. (Figure 
4.18).  
 
 
 
 
 
 
Figure 4.18: Structures of Auphen,RBA29, RBA31 and STAM013 provided by Cardiff University. 
This direct bond to the nitrogen atoms and the absence of the two chloride atoms may 
explain why RBA31 and STAM013 cannot bind to the AQP3, since it suggests that the gold metal 
is restrained and cannot bind to the accessible cysteine residues of AQP3, unlike Auphen that is 
bound to two chloride atoms.  On RBA29 structure, the gold metal is bound to two atoms of 
chloride as Auphen, suggesting that the metal is accessible to bind the AQP3 cysteine residues. 
This may explain the strong inhibition of glycerol transport exhibited for RBA29. About water 
permeability, RBA29 showed no inhibition of AQP1 and the effect of the other two compounds 
were not evaluated for water transport at that time but since it is an on-going work, water 
permeability in the presence of RBA31 and STAM013 will be assessed later on.  
 To study the inhibitory effect of these gold-based compounds on glycerol permeability, 
the IC50 value was calculated. The following graphs display the results obtained for the inhibition 
of glycerol permeability by RBA31, STAM013 and RBA29 and respective IC50 values (Figure 
4.19 and 4.20). 
 
 
 
Auphen RBA31 STAM013 RBA29 
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Figure 4.19: Inhibitory effect of RBA31 and STAM013 in RBCs glycerol permeability. A - Concentration 
dependent inhibition of glycerol permeability in RBCs by RBA31 for concentrations between 0.1-100 µM 
(incubated for 30 minutes at RT) with an IC50 > 50 µM (n=1). B – Concentration dependent inhibition of 
glycerol permeability in RBCs by STAM013 for concentrations between 0.1-100 µM (incubated for 30 
minutes at RT) with an IC50 > 50 µM (n=1). 
 
 
 As shown by Figure 4.19, both RBA31 and STAM013 slightly inhibited AQP3 glycerol 
permeability, presenting an IC50 value higher than 50 µM. Thus, these two gold-based compounds 
exhibit lack of potency in inhibiting AQP3 activity and so, they do not demonstrate potential to 
be AQP3 inhibitors. 
 
Figure 4.20: Inhibitory effect of RBA29 on RBCs glycerol permeability. A – Concentration dependent 
inhibition of glycerol permeability in RBCs by RBA29 for concentrations between 0.1-10 µM (incubated 
for 30 minutes at RT) with an IC50 value of (2.29 ± 0.03) µM (n=1). B – Stopped-flow signal for glycerol 
transport after imposing a hyperosmotic glycerol solution on the cells, for control RBCs and in the presence 
of 10 µM of RBA29 (concentration at which the compound already shows maximum inhibition). 
 RBA29 showed a very low IC50 value of (2.29 ± 0.03) µM, demonstrating that this gold 
compound strongly inhibited AQP3 glycerol transport. This is supported by the cell behaviour 
illustrated in Figure 4.20B, in which it is observed the drastically inhibition of AQP3 by RBA29 
B A 
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that could not facilitate the glycerol transport into the cells, preventing cell reswelling. Even 
though the gold metal from RBA29 was accessible to reach the AQP3 cysteine residues as much 
as Auphen, the IC50 values obtained were not the same since Auphen has a value of 0.8 µM that 
is lower than the one for RBA29 (2.29 µM).  
 Overall, RBA29 was the most promising of this set of gold compounds as a potential 
AQP3 inhibitor, with a low IC50 value (2.29 ± 0.03) µM and does not show potential to be an 
AQP1 inhibitor considering its lack of effect on water transport. Therefore, this compound 
exhibits great potency in inhibiting the glycerol transport in RBCs. 
4.1.3.2. Inhibitory effect of gold compounds in aquaporin-expressing 
yeast cells permeability 
 In order to assess the effect of RBA29, RBA31 and STAM013 in AQP9, they were tested 
in yeast cells transformed with plasmid encoding hAQP9. The results for their effect on glycerol 
permeability are shown in the next bar graph (Figure 4.21). 
 
Figure 4.21: Inhibitory effect of RBA29, STAM013 and RBA31 on glycerol permeability in hAQP9 at a 
concentration of 10 µM (incubation for 30 minutes at RT). Data are shown as media ± SEM for one 
experiment. Significance levels: *** P < 0.001, ** P < 0.01, compared to the control by student t-test. 
 In Figure 4.21, it was observed that the three gold compounds under study, strongly 
inhibited hAQP9 glycerol permeability, with a percent of inhibition between 65% and 80%. 
RBA29 showed that it can strongly inhibit both AQP9-expressing yeast cells and AQP3 in RBCs, 
revealing its potency and non-selectivity. On one hand, this compound has a structure composed 
by an accessible gold metal to bind to AQP3 cysteine residues as the potent glycerol permeability 
inhibitor Auphen. On the other hand, it has a hydroxyl group from the carboxylic acid that when 
deprotonated, can interact with the positively charged extracellular surface of AQP9. Regarding 
RBA31 and STAM013, they strongly inhibited AQP9, suggesting a potential selectivity to this 
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aquaporin, considering their lack of potency in inhibiting AQP3 in RBCs. Overall, it is important 
to study the structure/activity relationships for these three gold compounds to understand their 
binding sites. 
 Moreover, to study the inhibitory effect of RBA29 on hAQP9 glycerol permeability in 
yeast cells, it was calculated the IC50 value. The determination of the IC50 values for RBA31 and 
STAM013 was not yet possible since it is still an on-going work and the last experiments failed 
to obtain appropriate dose-response curves to their determination. The results for the AQP9 
glycerol permeability inhibition by RBA29 are displayed on the next graphs (Figure 4.22). 
 
Figure 4.22: Inhibitory effect of RBA29 on hAQP9 glycerol permeability. A - Concentration dependent 
inhibition of hAQP9 glycerol permeability by RBA29 for concentrations between 0.1-50 µM (incubated 
for 30 minutes at RT) with an IC50 value of (6.64 ± 0.09) µM (n=1). B – Time course of the relative cell 
volume changes after being exposed to a hyperosmotic glycerol solution, for cells transformed with plasmid 
encoding hAQP9 in the absence of compound and in the presence of 10 µM of RBA29.  
RBA29 showed a low IC50 value in the micromolar range of (6.64 ± 0.09) µM, confirming 
its potency in inhibiting the glycerol transport mediated by AQP9. Moreover, this is also 
supported by Figure 4.22B where the cells in the presence of RBA29, are unable to facilitate the 
glycerol transport because of AQP9 blockage, preventing the cell reswelling.  
Overall, these are promising results since there are no known potent and selective 
inhibitors of AQP9. Therefore, these new golds compounds must be validated in yeast 
transformed with plasmid encoding human AQP3 and repeat the assays with human AQP9 to then 
be tested in cancer cell lines in order to discover their anticancer properties. 
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4.2.  Functional assays of hAQP5 and important residues for permeability1 
AQP5 was found to be aberrantly expressed in a variety of human tumors and has been 
considered a potential therapeutic target and biomarker with prognostic value [78]. Thus, aiming 
to contribute for the design of new inhibitors able to modulate AQP5 in tumors, we expressed 
hAQP5 in yeasts and evaluated the important residues that are crucial for channel permeability. 
 
4.2.1. hAQP5 localization and function in the yeast plasma membrane 
 To evaluate the hAQP5 function, yeast cells (aqy-null cells) were transformed with either 
the empty vector pUG35 or the plasmid encoding hAQP5. First, the expression and localization 
of AQP5 at the yeast plasma membrane were evaluated by fluorescence microscopy using GFP-
tagging (Figure 4.23A). 
Figure 4.23: Localization, expression and function of hAQP5-expressing yeast cells. A – Phase contrast 
(left) and epifluorescence (right) microscopy images of yeast aqy-null cells transformed with plasmid 
encoding GFP-tagged human AQP5 (100× objective). B – Representative time course of relative cell 
volume (V/V0) changes after exposure to a hyperosmotic shock. C – Water permeability coefficients of 
control and hAQP5-expressing yeast cells before and after incubation with HgCl2 for 5 minutes at RT at 
pH 5.1. Data are shown as mean ± SEM of ten measurements. D – Activation energy for water permeability 
of control and hAQP5 cells. Data are shown as mean ± SEM of three independent experiments. Significance 
levels: *** P < 0.001, ns – nonsignificant, compared to the control by student t-test. 
 
1 Adapted from C. Rodrigues, C. Pimpão et al., “Human Aquaporin-5 Facilitates Hydrogen Peroxide 
Permeation and Cancer Cell Migration,” Cancers (Basel)., vol. 11, 2019. 
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As observed by Figure 4.23A, AQP5 is located in the membrane. Subsequently, the 
hAQP5 function was assessed by stopped-flow fluorescence where cells incubated with the 
volume sensitive dye CFDA, balanced in an isotonic solution, were mixed with a 2.1 M 
hyperosmotic sorbitol solution to evaluate water permeability. The experiments were performed 
at 23ºC for pH 5.1 and 5 signals were acquired. To obtain accurate permeability values, the 
software Berkeley Madonna was used to obtain Pf, using customized mathematical models as 
previously described. Moreover, the fluorescence signals were converted to relative cell volume 
to enable the direct visualization of the cell volume changes in response to an osmotic shock as 
shown in Figure 4.23B. When exposed to a hyperosmotic sorbitol solution, cells expressing 
hAQP5 reach the new osmotic equilibrium faster than control cells, indicating that hAQP5 
facilitates the water transport. Furthermore, the absolute values of water and glycerol permeability 
are useful to predict if the water and glycerol transport are being mediated by aquaporin channels 
or if these molecules are crossing the hydrophobic bilayer [6].  By Figure 4.23C, it is observed 
that the Pf value is 10-fold higher for AQP5-expressing yeast cells (3.70 ± 0.31) × 10
-3 cm/s than 
the Pf value for control cells (0.37 ± 0.03) × 10
-3 cm/s. When incubated with 0.5 mM HgCl2, that 
is a known potent and toxic inhibitor of aquaporins, there is a strong reduction on water 
permeability of the AQP5-expressing yeast cells, demonstrating that AQP5 is sensitive to mercury 
effect. Furthermore, the activation energies (Ea) was estimated from Arrhenius plot for a range of 
temperatures from 9ºC to 34ºC. It is known that water may cross cell membranes by two 
pathways: diffusion of water molecules across the hydrophobic bilayer (with high activation 
energy) and diffusion of water molecules through the channels (with low activation energy). 
Considering the flux of water across the membrane is the sum of the fluxes through these two 
pathways [5], [6], the activation energy needs to be measured to understand which pathway is 
dominant in the cell system. Therefore, if the activation energy is high, it means that water is 
crossing the hydrophobic bilayer and if it is low, then the water transport is being mediated by 
aquaporin. In Figure 4.23D, the activation energy was lower for AQP5-expressing cells (5.63 ± 
0.36) kcal.mol-1 than for the control cells (12.66 ± 0.69) kcal.mol-1. These results corroborate that 
the observed increase in water permeability is due to the expression of AQP5 that is functional 
and capable of water permeation. 
4.2.2. Role of hAQP5 residues in gating 
Recent evidences have revealed that human aquaporins can be gated by different 
mechanisms as pH or post-translational modifications as phosphorylation [103], [113]. 
Aquaporins’ regulation has been investigated to understand the gating mechanisms and which 
residues are involved in this regulation process. About AQP5, regulation was proposed to involve 
phosphorylation at Ser156 in cytoplasmatic loop D since its phosphomimetic mutation – S156E - 
led to increase of the relative membrane expression of AQP5 [82] in HEK293 cells, thereby 
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enhancing cancer cell proliferation. However, this mutation did not cause a significant structural 
change, suggesting that it is needed more than one phosphorylation site to generate a 
conformational change. Ser156 is a consensus PKA site in AQP5 that is often phosphorylated in 
certain tumors, such as in colon cancer cells, indicating that phosphorylation of AQP5 in Ser156 
mediate cell proliferation via Ras/ERK/Rb signalling pathway [114].  
Moreover, in silico studies have suggested another gating mechanism where the human 
AQP5 monomer experience conformational changes from open to close state and from wide to 
narrow state [115]. These studies proposed that AQP5 can change from open to closed state 
through a tap-like gating mechanism at the cytoplasmic end, by changing the orientation of His67 
ringed sidechain, being the key residue to completely block the water passage through the 
channel. Also, AQP5 can exhibit two different conformations: narrow state, where the residues 
His173 and Ser183 can restrict the water passage by being very close to each other (< 5.5 Å) and 
wide state that allows the passage of water molecules being the distance between the two residues 
higher than 7 Å and lower than 10 Å. Moreover, the authors found that the two states 
(wide/narrow) are determined by H173 side chain orientation wherein His173 ring flips into its 
mirror orientation in the wide state, and to switch to the narrow state, His173 sidechain returns to 
its normal orientation. In addition, a recent study from our lab with rAQP5 indicated that channel 
widening results from deprotonation when the protein is in the phosphorylated state [79]. 
Therefore, using the same yeast system, we investigated the gating mechanism for hAQP5 by 
phosphorylation and pH. The location of the residues previously mentioned are show in hAQP5 
monomer structure (Figure 4.24). 
 
 
Figure 4.24: Top view of human AQP5 monomer structure with phosphorylation consensus sites Ser156 
localized in intracellular loop D and Ser183 and His173 both localized in the selectivity filter. As proposed, 
when His67 side chain switches its orientation, it opens the channel, allowing the water passage. In such 
cases, if the proximity of His173 to Ser183 is higher than 7 Å and lower than 10 Å, the hAQP5 monomer 
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shows a wide conformation. Structures were generated with Chimera (http://www.cgl.ucsf.edu/chimera) 
and are based on the AQP5 X-ray structure (PDB databank code 3D9S). 
 It was generated point mutations in AQP5 selectivity filter and in intracellular loop D as 
shown in Figure 4.24, to investigate hAQP5 gating mechanisms. Mutations to change wide and 
narrow state were attained by substitution of histidine 173 (H173) with alanine (A) and with 
tryptophan (W), respectively, Furthermore, mutations to prevent the phosphorylation of S156 and 
S183 were obtained by substitution of serine (S) with alanine (A). Also, mutations to mimic the 
phosphorylation of hAQP5 in the previously mentioned serine residues, serine (S) was substituted 
with glutamic acid (E).  
 Water permeability of yeast cells transformed with plasmid encoding wild-type AQP5 
(AQP5 WT) or AQP5 mutants was determined at 23ºC at pH 5.1 and pH 7.4 (Figure 4.25A). In 
addition, expression and localization of all AQP5 mutants were confirmed at pH 5.1 and pH 7.4 
by fluorescence microscopy using GFP-tagging. All mutants exhibited similar GFP-fluorescence 
intensity at the plasma membrane. By Figure 4.25B, it was observed that all of them showed 
similar relative membrane expression, showing that differences in permeability cannot be 
assigned to impairment of AQP5 trafficking due to mutations. 
Figure 4.25: Residues involved in water permeability through hAQP5. A – Water permeability values for 
control cells and for yeast transformed with plasmid encoding AQP5 WT and mutants, at 23ºC at pH 5.1 
and pH 7.4. Data are shown as mean ± SEM of 10 measurements. B – Relative membrane expression of 
AQP5 WT and mutants for pH 5.1 and pH 7.4, calculated from fluorescence intensity profiles (10 cells in 
each experimental condition, 4 profiles for each cell, from at least 3 independent experiments). Significance 
levels: *** P < 0.001, ns – nonsignificant, compared to the control by student t-test.  
 
 Permeability experiments with control cells, AQP5 WT and mutants performed at two 
pHs (pH 5.1 and pH 7.4), showed that alteration of external pH did not affect water permeability, 
and that this is not dependent on aquaporin phosphorylation.  As already mentioned, a recent 
study proposed that phosphomimetic mutation S156E increased the AQP5 relative membrane 
expression in HEK293 cells [82]. In this present work, preventing or mimicking S156 
phosphorylation did not alter AQP5 membrane expression (Figure 4.25B), nor did it modify 
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AQP5 water permeability at any pH tested, which may be in part explained by a different 
signalling pathway for AQP5 trafficking used by yeasts. In the case of histidine, water 
permeability was impaired when it was mutated (H173A and H173W). It is known that histidine 
is a highly conserved residue in the selective filter of orthodox aquaporins, being essential to their 
selectivity and water transport [116], [117]. Thus, the histidine importance for the selectivity filter 
was validated by the completely blockage of water transport when H173 was mutated. About 
S183 residue, Figure 4.24A showed that the prevention of phosphorylation by S183A mutation 
did not affected water permeability, indicating that AQP5 channel remains in the wide state and 
that the distance between S183 and H173 side chain is higher than 7 Å and lower than 10 Å. 
Concerning the phosphomimetic mutation S183E, water permeability was totally blocked, 
suggesting that the proximity of S183 to H173 side chain is lower than 5.5 Å, probably due to the 
negatively charged group that leads to the narrow state.  
Overall, these mutagenesis studies demonstrated that phosphorylation of S156 does not 
affect water permeability at the cytoplasmatic end, that H173 is a highly conserved residue in the 
selectivity filter and its interaction with phosphorylated S183 possibly results in pore constriction. 
In particular, the phosphorylation of S183 at the selectivity filter represents a new AQP5 gating 
mechanism that has never been reported, unveiling the important residues for water permeation, 
further contributing to the design of new drugs. 
4.3. Functional assays of aquaporins from diverse organisms 
The aim of this part of the work was to investigate aquaporins from diverse organisms for 
University of Copenhagen and Aquaporin A/S company. This company takes advantage of 
aquaporins strictly selective to water, to develop water filtering devices to be employed in the 
industry and in household for water filtration and purification [118]. For this purpose, they 
developed a biomimetic membrane for the selective transport of water since biological 
membranes exhibit mechanical and chemical stability to a wide range of various external stress 
factors unlike the traditional polymeric separation membranes. This biomimetic membrane is 
composed by lipids, artificial components mimicking block-copolymers and the aquaporin 
protein to generate an artificial water filtration membrane. Nowadays, this technology is available 
for both forward osmosis (FO) and reverse osmosis (RO) applications. FO consists in two aqueous 
solution, one with low solute concentration and one with high solute concentration, which 
concentration differences leads to solute or water transport to equalize the system. By adding a 
semi-permeable membrane that does not permit solute transport, the only way for the system to 
equilibrate is by water transport from one side to the other. This allows to induce a water flux that 
will result in bringing the water to one side and concentrating the solute in the other side.  
Therefore, the products available for forward osmosis are mostly applied to high rejection of 
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contaminants and/or retaining valuable compounds. Whereas FO happens naturally without 
energy required, in reverse osmosis it is needed to apply energy to the highest solute concentrated 
solution [119]. For RO, it is also used a semi-permeable membrane that allows the passage to 
water molecules but not most salts, bacteria, among others. Nevertheless, it is needed to apply a 
pressure higher than the natural osmotic pressure to obtain pure water with most of the solutes 
retained. Thus, the products available for reverse osmosis are mostly applied to produce high-
quality water and for seawater desalination. 
The production of biomimetic membranes with aquaporin inside, led to the need of 
discovering aquaporins with higher selectivity, high water permeability, more stable and resistant 
to external factors. Accordingly, in University of Copenhagen, yeast cells were transformed with 
plasmid encoding eight aquaporins in the pUG35 vector (aqy-null cells) from different species: 
- Three plant aquaporins: eucalyptus (Eucalyptus globulus), rice (Oryza sativa) and 
potato (Solanum tuberosum); 
- One tardigrade (Hypsibius dujardini) aquaporin; 
- Four bacterial aquaporins: Methanocella conradii, Kyrpidia tusciae, 
Methanothermobacter thermautotrophicus and Novibacillus thermophilus. 
Concerning plant aquaporins, there are evidences that eucalyptus, rice and potato are 
associated with drought tolerance [120]–[122]  and also with salt resistance in the case of rice. 
About the tardigrades [123], these are small invertebrate that are known for their capacity of 
surviving complete dessecation by undergoing anhydrobiosis (survive the loss of all water). In 
this anhydrobiotic condition, they enter in a dormancy state wherein metabolism and aging stops. 
Besides this great capacity, tardigrades can survive to all kind of environments since they are 
resistant to extreme temperatures and pressures, starvation and radiation. Regarding the four 
bacterial aquaporins, they are all known thermophiles with resistance to extreme high 
temperatures.  
Overall, the goal of this work section is to discover an aquaporin selective to water with 
high water permeability, resistant to stress factors and stable. Therefore, yeast cells were 
transformed with either the empty vector or with the plasmid encoding the aquaporins under 
study. The assessment of the aquaporins function was assessed by stopped-flow fluorescence 
where cells incubated with the volume sensitive dye CFDA, balanced in an isotonic solution, were 
mixed with a 2.1 M hyperosmotic sorbitol solution to evaluate water permeability or with a 2.1 
M hyperosmotic glycerol solution to evaluate glycerol permeability. The experiments were 
performed at 23ºC for pH 5.0 and pH 7.4 and 5 signals were acquired for each organism. To obtain 
accurate permeability values, the software Berkeley Madonna was used to obtain Pf and Pgly, using 
customized mathematical models as previously described. The glycerol permeability at pH 5.0 
could not be calculated as it was not possible to exponentially fit the obtained signals for both 
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control cells and for each aquaporin tested. The results for the glycerol and water permeability 
values for the control cells and for each aquaporin tested at pH 5.0 and pH 7.4, are shown in the 
next bar graph (Figure 4.26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.26: Water and glycerol permeability coefficients for pH 5.0 and pH 7.4 for the eight aquaporins 
under study. A – Water permeability values for control cells and yeast transformed with plasmid encoding 
the aquaporins of interest, at 23ºC for pH 5.0 and pH 7.4. B – Glycerol permeability values for control cells 
and yeast transformed with plasmid encoding aquaporins of interest, at 23ºC for pH 7.4. Data are shown as 
media ± SEM for two measurements. Significance levels: **** P < 0.0001, *** P < 0.001, ** P < 0.01, * 
P < 0.05, ns – nonsignificant, compared to the control by student t-test. 
 
Water permeability coefficients for pH 5.0 and pH 7.4 were very similar, showing that 
the alteration of the external pH does not affect water permeability in any of the aquaporins. For 
pH 5.0, all the aquaporins that exhibit low water permeability showed statistical significance, 
however the water transport mediated by these aquaporins is not biologically relevant since their 
permeability values were similar or even lower than the value for control cells water permeability. 
A 
B 
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Also, for glycerol permeability values, almost all aquaporins-expressing yeast cells showed 
statistical significance relative to the control cells, but biologically they are not relevant since the 
permeability values are lower or very similar to the glycerol permeability value for control cells. 
By Figure 4.26A, it is observed that tardigrade and M. thermautotrophicus aquaporins exhibited 
the highest water permeabilities from all the compounds: (2.64 ± 0.28) × 10-3 cm/s and (1.24 ± 
012) × 10-3 cm/s, respectively. Moreover, Pf value for the tardigrade aquaporin is 2-fold higher 
than Pf value for M. thermautotrophicus aquaporin and 5-fold higher that the permeability value 
for control cells ((0.50 ± 0.01) × 10-3 cm/s). These high permeability values associated with the 
fact that these two aquaporins do not transport glycerol, reveal that tardigrade and M. 
thermautotrophicus aquaporins are the most functional water channels with high permeability and 
selectivity for these molecules, to be then applied in biomimetic membranes for water filtration. 
Moreover, to confirm these high permeabilities for water and that these molecules are actually 
being transported by the aquaporins and not crossing the hydrophobic bilayer, Ea were estimated 
from Arrhenius plot for a range of temperatures from 9ºC to 34ºC for pH 5.0 and pH 7.4. (Figure 
4.27) 
Figure 4.27: Arrenhius plot for water permeability assays at pH 5.0 and pH 7.4 for control cells and M. 
thermautotrophicus and tardigrades aquaporins-expressing yeast cells. A – Arrhenius plot for water 
permeability assays at pH 5.0 for yeast transformed with the empty vector and transformed with plasmid 
encoding M. thermautotrophicus and tardigrade aquaporins, for a range of temperatures from 9ºC to 34ºC. 
B - Arrhenius plot for water permeability assays at pH 7.4 for yeast transformed with the empty vector and 
transformed with plasmid encoding M. thermautotrophicus and tardigrade aquaporins, for a range of 
temperatures from 9ºC to 34ºC 
 
Table 4.1: Activation energy values calculated from the slope determined from the experimental points 
using simple linear regression. 
 
Ea (kcal.mol
-1
) 
pH 5.0 pH 7.4 
pUG35 (empty vector) 14.38 ± 0.22 14.32 ± 0.34 
M. thermautotrophicus 
Aquaporin 
11.52 ± 0.68 14.58 ± 1.02 
Tardigrade Aquaporin 8.40 ± 0.70 11.05 ± 1.75 
A B 
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 Ea measures the energy barrier to water movement across a membrane. When the water 
transport is across the lipid membrane, the Ea is generally high (>8-10 kcal.mol
-1) since the water 
molecules are interacting with the lipid molecules. When the water transport is mediated by an 
aquaporin channel, Ea is generally lower (3-6 kcal.mol
-1) [6]. From Figure 4.27 and Table 4.1, it 
is observed differences for activation energy values by alteration of the external pH from pH 5.0 
to pH 7.4, indicating that at pH 5.0, aquaporins exhibit higher permeability probably due to higher 
aquaporin expression, which agrees with the fact that this pH is optimal for yeast growth. At pH 
5.0, M. thermautotrophicus and tardigrade aquaporins exhibited Ea values of (11.52 ± 0.68) 
kcal.mol-1 and (8.40 ± 0.70) kcal.mol-1, respectively that are lower than Ea value for empty vector: 
(14.38 ± 0.22) kcal.mol-1. Even though the literature considers 8 kcal.mol-1 in the threshold for 
the absence of aquaporin water channels, the tardigrade aquaporin reveals to be functional and 
capable of mediating water transport with high water permeability, when compared to Ea value 
for the control cells. However, the difference from the activation energy for M. 
thermautotrophicus and the Ea value for control cells suggests that this aquaporin is not functional, 
which is confirmed when comparing to the literature values. At pH 7.0, tardigrade aquaporin 
presents an Ea value of (11.05 ± 1.75) kcal.mol
-1, being the lowest energy activation comparing 
with the similar Ea values for M. thermautotrophicus aquaporin and control cells: (14.58 ± 1.02) 
kcal.mol-1 and (14.32 ± 0.34) kcal.mol-1, respectively. Comparing with the literature, the 
tardigrade aquaporin at this pH does not appear to be functional. Therefore, yeast transformed 
with plasmid encoding tardigrade AQP at pH 5.0, has revealed to be the most promising 
aquaporins in water transport from all the ones tested, exhibiting water selectivity, with high water 
permeability values. These features combined with the remarkable resistance to stress 
environments and survival when exposed to multiple external factors as extreme temperature and 
pressure, dessecation and starvation, unveil the great potential of this aquaporin to be employed 
in biomimetic membranes capable of water filtration associated with possible industrial and 
household applications. 
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5. Conclusions 
 
 This thesis was focused on the assessment of aquaporins function and in the discover of 
potential inhibitors that could target aquaporins overexpressed in cancer and prevent cell 
processes responsible for tumor development as cell proliferation and migration. 
 In the first part of the thesis, eleven polyoxometalates were screened in RBCs and 
validated in aquaporin-expressing yeast cells to evaluate their inhibitory effect on aquaporins 
permeability. By RBCs assays, POT-A was identified as the most promising inhibitor of AQP3, 
exhibiting a low IC50 value of (0.71 ± 0.04) µM which shows the great potency of this compound 
in inhibiting the glycerol permeability. Moreover, this compound slightly inhibited the water 
permeability, probably due to the inhibitory effect on AQP3, that also transports water besides 
glycerol. Through yeast assays, the potency of this compound was confirmed by the near 100% 
inhibition on AQP3-expressing yeast. In addition, POT-A did not inhibit AQP7 and AQP9, 
suggesting the selectivity towards AQP3. Considering that Auphen has a similar IC50 value to 
POT-A and that it inhibits both AQP3 and AQP7, POT-A appears to be a suitable drug candidate 
for targeting AQP3 in cancer, where AQP3 is overexpressed. POT-A is being tested in cancer cell 
lines, in particular pancreatic cancer (on-going studies in our lab), to investigate its anticancer 
properties. Further studies are needed to establish structure/activity relationships and understand 
the effect of POT-A in AQP10 that was still not tested. 
 On the second part of the thesis work, vanadium, copper and zinc compounds were tested 
in RBCs in the same conditions as for polyoxometalates. P103, a compound with a vanadium 
metal and two molecules of Amphen, revealed to be the most promising compound in inhibiting 
AQP1 with an IC50 value of (9.11 ± 0.03) µM. This is an important discovery considering there 
are no known AQP1 inhibitors until now that show great potency in AQP1 inhibition as P103. In 
the future, it is essential to study its reversibility in binding AQP1, establish structure/activity 
relationships and to validate these results by testing P103 in aquaporin-expressing yeast cells and 
cancer cell lines to comprehend if it has potential to be used in AQP1-overexpressing cancers 
treatment. 
 In the third study performed during this thesis, gold compounds were tested in RBCs and 
validated in yeast transformed with plasmid encoding aquaporins. In RBCs assays, RBA29, that 
was studied for its potential for AQP9 inhibition, was the most promising from the set of gold-
based compounds as a potential AQP3 inhibitor, exhibiting an IC50 value of (2.29 ± 0.03) µM and 
lack of effect on water transport mediated by AQP1. By yeast assays, RBA29, RBA31 and 
STAM013 showed AQP9 inhibition, being the IC50 value for RBA29 of (6.64 ± 0.09) µM. These 
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are very promising results considering there are no known AQP9 inhibitors until now with such 
potency. Therefore, the validation of these results in AQP3-expressing yeast cells, AQP9-
expressing yeast cells and in cancer cell lines is of utmost importance.  
 In the fourth part of this work, the important residues for AQP5 permeability were 
investigated, Moreover, mutagenesis studies demonstrated that while phosphorylation of S156 at 
the cytoplasmic end does not affect AQP5 permeability, His173 located in the selectivity filter 
revealed to be crucial for water permeability and possibly interacts with phosphorylated S183 for 
permeability regulation, resulting in the blockage of the pore. This reported gating mechanism 
has never been described before, unveiling the important residues for water permeation, 
contributing to the design of novel selective and potent inhibitors with potential for cancer 
therapeutics. 
 In the final section of this thesis, the function of aquaporins from diverse organisms was 
assessed with the goal of understanding their features as selective water channels with potential 
application in biomimetic membranes for water filtration. The aquaporin from tardigrade revealed 
as the most promising in terms of water selectivity, high water permeability in addition with the 
remarkable advantage of possessing high resistance to numerous external factors as extreme 
temperature and pressure, dessecation, starvation and radiation. Therefore, this aquaporin has 
great potential to be employed in biomimetic membranes, capable of water filtration. 
 Overall, POT-A, P103 and gold-based compounds tested revealed as suitable drug 
candidates to be applied in cancer treatment where AQP1, AQP3 and AQP9 are overexpressed. 
In fact, few aquaporin inhibitors have been described until now, which demonstrates the great 
outcome from these AQP-modulators studies performed during this work. Moreover, the 
disclosure of a new gating mechanism for AQP5 and of the important residues for water 
permeation may be used for the design of selective modulators. Altogether, these results 
contribute to new aspects of aquaporin research that may be used in benefit of pharmaceutics 
(drug discovery and drug design) and industry (in terms of water filtering systems).  
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